This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of breast, HER-negative
C3_BREAST_ERNEG
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditions
|
277748 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
8561 |
4. Check minimum number of eventsNone |
8561 |
5. Include endpointsNone |
8561 |
6. Filter based on genotype QC (FinnGen only) |
8561 |
Control definitions (FinnGen only)
- Control conditions
- not RX_ERPLUS
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of breast, HER-negative
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of breast
- Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 8561 | 8561 | - |
| Unadjusted period prevalence (%) | 2.92 | 2.92 | - |
| Median age at first event (years) | 58.07 | 58.07 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 8764
- Matched controls
- 87584
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
41.8
323.0
445
112
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
96.5
323.0
535
59
A04AA02
ATC
granisetron; systemic, transdermal
9.3
323.0
1204
1470
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.1
323.0
3909
17998
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
910.8
323.0
434
5
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
179.0
323.0
678
41
C50
ICD-10 Finland
Malignant neoplasm of breast
445.8
323.0
1171
30
XX3DW
NOMESCO Finland
Time consuming IT work
8.2
323.0
2118
3263
A04AA55
ATC
palonosetron, combinations; systemic
30.5
323.0
1135
424
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
392.2
323.0
3440
144
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
310.5
323.0
737
26
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
19.1
323.0
1137
679
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
299.6
323.0
2772
135
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
536.5
323.0
603
12
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
50.5
323.0
586
124
HAB99
NOMESCO Finland
Other partial excision of mammary gland
27.1
323.0
987
408
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
29.7
323.0
1670
688
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
94.3
323.0
782
91
ZX080
NOMESCO Finland
Image guided radiotherapy
37.3
323.0
687
199
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
1183.5
323.0
450
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
10.6
323.0
697
707
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
111.0
323.0
473
45
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
28.2
323.0
815
317
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
228.9
323.0
1610
86
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
4801.1
323.0
466
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
20.9
323.0
2453
1601
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
263.7
323.0
427
17
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
483.3
323.0
590
13
A03FA01
ATC
metoclopramide; systemic, rectal
4.0
323.0
3243
11272
X76
ICPC
Malignant neoplasm breast female
309.5
323.0
735
26
Z31.5
ICD-10 Finland
Genetic counselling
7.0
323.0
927
1446
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
78.4
323.0
1083
157
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
323.0
453
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
323.0
1249
*
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
30.1
323.0
469
164
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
692.8
323.0
933
15
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
263.4
323.0
474
19
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
323.0
3519
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
98.7
323.0
1599
197
HAB40
NOMESCO Finland
Wedge excision of mammary gland
143.3
323.0
3240
357
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
197.7
323.0
659
36
C50.99
ICD-10 Finland
Breast, unspecified
236.1
323.0
1508
77
HAC20
NOMESCO Finland
Total mastectomy
397.2
323.0
2156
72
HA1AA
NOMESCO Finland
X-ray mammography
20.0
323.0
2893
2110
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
533.1
323.0
1868
44
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
241.8
323.0
1064
50
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
174.6
323.0
495
30
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
52.9
323.0
773
160
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
166.5
323.0
591
38
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
420.4
323.0
809
21
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
74.0
323.0
1672
278
PJA12
NOMESCO Finland
Sentinel node biopsy
140.2
323.0
4604
687
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
59.0
323.0
1231
242
TQW20
NOMESCO Finland
Tatoe
160.2
323.0
485
32
N63
ICD-10 Finland
Unspecified lump in breast
6.1
323.0
1455
2762
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
238.8
323.0
663
30
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
323.0
379
*
H02AB02
ATC
dexamethasone; systemic
10.2
323.0
2382
3084
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
338.6
323.0
739
24
XX1XN
NOMESCO Finland
Other isotope examination
307.0
323.0
463
16
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
206.5
323.0
1087
60
L02BG04
ATC
letrozole; oral
28.2
323.0
742
286
115
Kela drug reimbursment
Breast cancer
5466.1
323.0
3295
9
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
20.2
323.0
1522
901
ZX090
NOMESCO Finland
Other technic of radiotherapy
15.9
323.0
590
396
L03AA14
ATC
lipegfilgrastim; parenteral
18.4
323.0
545
315
L03AA13
ATC
pegfilgrastim; parenteral
17.4
323.0
1047
676
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
323.0
1132
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.1
323.0
2734
11145
NK6AN
NOMESCO Finland
Total body bone isotope imaging
37.4
323.0
462
130
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
17.4
308.5
500
303
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
248.6
304.8
312
13
WX402
NOMESCO Finland
General anaesthesia
3.1
301.3
2005
7691
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
1513.7
297.2
288
*
L02BA01
ATC
tamoxifen; oral
88.3
281.4
315
37
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
68.7
280.8
325
49
WZC30
NOMESCO Finland
Teaching
3.3
280.0
1632
5662
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
325.3
278.1
281
9
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
6.3
277.3
790
1355
HAE99
NOMESCO Finland
Other reconstruction of breast
77.8
276.9
315
42
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
319.1
272.9
276
9
A04AD12
ATC
aprepitant; systemic
17.3
266.4
432
261
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
246.9
236
*
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
410.0
241.0
241
6
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.8
232.6
838
1881
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
29.4
229.8
315
111
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
6.5
223.9
622
1024
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
91.7
216.4
241
27
ZZR10
NOMESCO Finland
Flap of skin and muscle
45.8
215.5
267
60
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
144.8
212.5
226
16
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
144.2
211.4
225
16
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
425.3
209.2
209
5
L01BC06
ATC
capecitabine; oral
6.1
207.6
602
1046
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
269.3
205.9
210
8
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
12.0
205.3
389
338
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
304.8
204.2
207
7
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
15.3
202.0
343
232
HAC25
NOMESCO Finland
Radical mastectomy
1870.9
199.5
193
*
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
135.6
198.2
212
16
R4110
NOMESCO Finland
Physiotherapy
2.2
196.2
2741
15222
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
490.7
194.1
193
*
A04AA01
ATC
ondansetron; systemic, rectal
3.6
188.1
929
2772
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
14.8
187.6
323
226
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
7.3
183.0
461
658
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
+∞
182.9
175
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
163.4
182.3
192
12
9703
FHL
Breast resection
12.7
181.2
334
273
TQB05
NOMESCO Finland
Puncture of skin of trunk
28.1
166.1
230
84
1CD02
NOMESCO Finland
NA
138.0
164.8
176
13
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
159.8
153
*
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
53.0
159.4
192
37
8010/3-C50.9
ICD-O-3
Carcinoma, NOS, of breast, NOS
+∞
156.7
150
*
FM1FN
NOMESCO Finland
Heart function isotope examination
75.3
155.1
177
24
HAD99
NOMESCO Finland
Other plastic operation on breast
40.2
152.0
193
49
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
+∞
147.2
141
*
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
28.9
146.5
201
71
ZZF00
NOMESCO Finland
Graft of adipose tissue
22.3
146.1
216
99
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
35.7
145.0
189
54
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
170.5
143.9
151
9
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
360.3
142.2
143
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
294.4
141.8
144
5
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
25.2
140.4
200
81
9706
FHL
Ablation mammae, includes axillary exploration
1381.2
138.9
135
*
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
26.8
137.2
192
73
5702
FHL
Local lymph node removal (eg armpit, groin)
46.5
137.1
169
37
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
+∞
136.8
131
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
78.7
129.7
147
19
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
110.1
129.3
141
13
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
194.2
128.9
134
7
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
642.1
128.7
127
*
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
1265.9
128.4
125
*
WF002
NOMESCO Finland
Radical radiotherapy
5.3
128.2
413
808
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
12.6
126.8
233
189
HAD40
NOMESCO Finland
Mastopexy
30.2
122.5
166
56
1749X
ICD-9 Finland
Malignant neoplasm of female breast, Breast (female), unspecified
251.4
121.2
124
5
1742A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-inner quadrant
1183.7
120.1
117
*
D05.0
ICD-10 Finland
Lobular carcinoma in situ
159.6
119.5
126
8
HA4MT
NOMESCO Finland
Labeling mammary gland pathology with X-ray guidance
60.4
116.4
137
23
WX702
NOMESCO Finland
Supraglottic ventilation device
3.3
112.4
609
1926
Z51.0
ICD-10 Finland
Radiotherapy session
13.8
110.2
194
143
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
55.9
106.6
127
23
HA6HA
NOMESCO Finland
Tomosynthesis assessment of mammary gland specimen
106.8
106.2
116
11
L03AA02
ATC
filgrastim; parenteral
5.2
104.2
343
686
HA3ST
NOMESCO Finland
Removal of lesion of breast with radiological guidance
29.4
104.2
142
49
HA1HA
NOMESCO Finland
Tomosynthesis mammography
24.6
103.4
148
61
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.1
103.2
434
1112
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
104.0
103.1
113
11
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
78.4
102.4
116
15
HWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of mammary gland
43.3
99.4
124
29
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
71.3
98.5
113
16
X21
ICPC
Breast sympt/compl female other
5.1
96.4
322
655
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
477.6
95.5
95
*
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
239.8
92.7
95
*
JN4BD
NOMESCO Finland
Extensive body CT
2.3
92.1
946
4378
C50.5
ICD-10 Finland
Malignant neoplasm: Lower-outer quadrant of breast
907.3
92.0
90
*
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
23.5
91.1
132
57
C50.52
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor
897.0
90.9
89
*
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
308.8
89.9
91
*
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
886.8
89.9
88
*
HA1SA
NOMESCO Finland
Expansion mammography
31.7
89.1
119
38
1748X
ICD-9 Finland
Malignant neoplasm of female breast, Other specified sites of female breast
+∞
88.6
85
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
7.3
88.2
220
308
1XC03
NOMESCO Finland
NA
156.5
88.2
93
6
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
12.5
88.1
162
132
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
436.7
87.2
87
*
PJW99
NOMESCO Finland
Other operation on lymphatic system
118.7
87.0
94
8
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
298.2
86.8
88
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
19.3
86.1
133
70
ZX112
NOMESCO Finland
Subcutaneous
5.9
85.6
250
434
8500/2-C50.4
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast
+∞
84.5
81
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
9.1
84.2
182
203
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
65.3
83.6
97
15
8520/2-C50.9
ICD-O-3
Lobular carcinoma in situ, NOS, of breast, NOS
+∞
83.4
80
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
35.2
83.0
108
31
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
22.1
82.7
122
56
ZXA05
NOMESCO Finland
Left side
1.7
81.0
2369
15980
1745A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-outer quadrant
+∞
80.3
77
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
43.4
79.6
99
23
8510/3-C50.9
ICD-O-3
Medullary carcinoma, NOS, of breast, NOS
+∞
78.2
75
*
HWH99
NOMESCO Finland
Other reoperation in surgery of mammary gland
38.5
77.6
99
26
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.5
77.5
651
2707
C50.30
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication
754.4
76.4
75
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
10.6
76.3
152
146
JN4AD
NOMESCO Finland
Body CT examination
2.5
76.2
672
2868
WB610
NOMESCO Finland
Demanding neoadjuvant therapy of tumour with antibodies
118.1
76.0
82
7
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.5
75.3
369
1075
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
6.8
72.0
188
282
ZX120
NOMESCO Finland
Intravenous
2.2
71.4
813
3921
X19
ICPC
Breast lump/mass female
4.9
70.9
242
504
ZXA00
NOMESCO Finland
Right side
1.6
69.6
2444
17160
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
4.6
68.5
249
554
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
68.3
2182
14941
8480/3-C50.9
ICD-O-3
Mucinous adenocarcinoma of breast, NOS
+∞
67.8
65
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
14.2
66.0
114
81
L02BG06
ATC
exemestane; oral
+∞
65.7
63
*
C50.01
ICD-10 Finland
Malignant tumor of nipple and areola, ductal tumor
67.7
64.3
74
11
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
9.0
64.0
139
157
HA1S1
NOMESCO Finland
Photography of breasts
54.7
63.9
76
14
XX1AD
NOMESCO Finland
Other CT-examination
14.1
63.4
110
79
8503/2-C50.9
ICD-O-3
Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS
+∞
62.5
60
*
C50.3
ICD-10 Finland
Malignant neoplasm: Lower-inner quadrant of breast
314.0
62.4
63
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.1
62.1
176
295
8140/3-C50.9
ICD-O-3
Adenocarcinoma, NOS, of breast, NOS
+∞
61.5
59
*
N64.9
ICD-10 Finland
Disorder of breast, unspecified
5.4
60.0
186
348
D24
ICD-10 Finland
Benign neoplasm of breast
3.5
59.2
291
850
N64.5
ICD-10 Finland
Other signs and symptoms in breast
3.4
59.0
307
937
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
30.2
58.0
78
26
HAA10
NOMESCO Finland
Biopsy of mammary gland
6.3
58.0
160
259
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
13.6
57.5
101
75
N02BE01
ATC
paracetamol; systemic, rectal
1.6
57.4
7557
69429
9725
FHL
Reconstruction of the mammary gland with foreign material (after removal)
49.6
57.1
69
14
ZX070
NOMESCO Finland
Intensity modified radiotherapy
5.5
57.0
174
320
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.5
55.7
272
790
D05.7
ICD-10 Finland
Other carcinoma in situ of breast
+∞
55.2
53
*
1743A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-inner quadrant
530.8
53.5
53
*
C50.32
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor
267.2
52.1
53
*
C50.09
ICD-10 Finland
Malignant tumor of nipple and areola, other or undeterminated histology
+∞
52.1
50
*
17409
ICD-8 Finland
Malignant neoplasm of breast, Unspecified
180.9
51.9
54
*
HA1AE
SPAT
NA
4.1
51.8
212
530
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.4
49.2
245
724
9702
FHL
Breast exploration and possible tumor removal
3.4
48.9
253
770
ZSZ00
NOMESCO Finland
Primary repair operation
106.6
48.8
53
5
8520/3-C50.2
ICD-O-3
Lobular carcinoma, NOS, of upper-inner quadrant of breast
+∞
47.9
46
*
XX9TE
NOMESCO Finland
Compementary ultrasound examination
7.9
47.8
112
144
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.1
46.8
560
2744
1741A
ICD-9 Finland
Malignant neoplasm of female breast, Central portion
236.0
46.0
47
*
X26
ICPC
Fear of breast cancer female
7.0
45.3
115
167
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.5
44.6
356
1432
9719
FHL
Other measure in this category
17.6
44.4
70
40
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
43.4
860
5070
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
4.2
42.9
169
409
L02BG03
ATC
anastrozole; oral
94.5
42.8
47
5
8000/3-C50.9
ICD-O-3
Neoplasm, malignant of breast, NOS
+∞
42.7
41
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
42.0
3254
26216
8522/3-C50.4
ICD-O-3
Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast
+∞
41.7
40
*
N05CB02
ATC
barbiturates in combination with other drugs
2.4
39.9
366
1586
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
39.8
3333
27129
D05
ICD-10 Finland
Carcinoma in situ of breast
+∞
39.6
38
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
39.3
745
4326
L01CA04
ATC
vinorelbine; systemic
8.4
39.0
87
104
HA1BA
NOMESCO Finland
Extensive X-ray mammography
8.0
39.0
90
114
8522/3-C50.9
ICD-O-3
Infiltrating duct and lobular carcinoma of breast, NOS
+∞
38.5
37
*
HA1ST
NOMESCO Finland
Biopsy of mammary gland with sterotactic guidance
24.7
38.3
54
22
8211/3-C50.9
ICD-O-3
Tubular adenocarcinoma of breast, NOS
+∞
37.5
36
*
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
7.2
36.8
91
128
HAD00
NOMESCO Finland
Augmentation mammoplasty
32.1
36.5
48
15
R50.9
ICD-10 Finland
Fever, unspecified
1.6
35.8
915
5795
2330A
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Breast
348.4
34.9
35
*
N60.8
ICD-10 Finland
Other benign mammary dysplasias
7.3
34.9
85
117
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
15.5
34.6
57
37
B01AB05
ATC
enoxaparin; parenteral
1.4
34.4
2525
19975
HA1DA
NOMESCO Finland
Restricted mammography
25.4
34.4
48
19
9721
FHL
Mamilla reconstruction or transposition
51.4
34.4
41
8
8520/3-C50.5
ICD-O-3
Lobular carcinoma, NOS, of lower-outer quadrant of breast
+∞
34.4
33
*
156
Kela drug reimbursment
Lapatinib
+∞
33.3
32
*
8520/3-C50.1
ICD-O-3
Lobular carcinoma, NOS, of central portion of breast
+∞
33.3
32
*
HAD20
NOMESCO Finland
Liposuction of breast
23.6
33.0
47
20
WB321
NOMESCO Finland
Multiple adjuvant therapy of malignancy with biomodifiers
74.4
32.8
37
5
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.4
32.8
284
1196
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
16.9
32.7
52
31
XX1XT
NOMESCO Finland
Other puncture with other radiological guidance
14.5
32.6
55
38
QBJ00
NOMESCO Finland
Liposuction in trunk
6.8
32.5
83
123
C50.0
ICD-10 Finland
Malignant neoplasm: Nipple and areola
318.0
31.9
32
*
HA1RA
SPAT
NA
2.4
31.8
287
1236
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
4.9
31.6
106
220
R92
ICD-10 Finland
Abnormal findings on diagnostic imaging of breast
6.4
31.3
84
133
9708
FHL
Radical mastectomy (Halsted), also involves removal of the parasternal gland
+∞
31.3
30
*
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
2.8
31.2
207
750
Z31.6
ICD-10 Finland
General counselling and advice on procreation
11.2
31.1
59
53
N62
ICD-10 Finland
Hypertrophy of breast
2.1
31.1
384
1903
QBA00
NOMESCO Finland
Puncture of skin of trunk
9.0
30.4
65
73
2393A
ICD-9 Finland
Neoplasm of unspecified nature, Breast
5.5
30.2
91
167
L01XE07
ATC
[U] lapatinib; oral
+∞
30.2
29
*
9724
FHL
Breast augmentation or reconstruction with own tissue
24.8
30.0
42
17
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
8.0
29.7
68
86
8500/2-C50.5
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of lower-outer quadrant of breast
+∞
29.2
28
*
WX110
NOMESCO Finland
Local anesthesy
1.3
29.1
5287
47304
N61
ICD-10 Finland
Inflammatory disorders of breast
2.8
29.0
191
689
N06AX16
ATC
venlafaxine; oral
1.5
28.6
1037
7138
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
21.1
28.6
42
20
XX2VW
NOMESCO Finland
Radiologic consultation
6.1
28.2
78
129
XX2ET
NOMESCO Finland
NA
+∞
27.1
26
*
A02BC02
ATC
pantoprazole; systemic
1.3
27.0
5453
49201
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
2.7
27.0
186
691
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
18.7
26.9
41
22
1740A
ICD-9 Finland
Malignant neoplasm of female breast, Nipple and areola
140.3
26.6
28
*
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
16.9
26.5
42
25
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
23.2
26.0
37
16
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.7
25.6
537
3210
A79
ICPC
Malignancy NOS
4.1
25.3
99
241
8211/3-C50.4
ICD-O-3
Tubular adenocarcinoma of upper-outer quadrant of breast
+∞
25.0
24
*
8523/3-C50.4
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of upper-outer quadrant of breast
+∞
25.0
24
*
8523/3-C50.9
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of breast, NOS
+∞
25.0
24
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
3.3
24.9
129
397
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
5.7
24.9
72
127
3AA13
NOMESCO Finland
NA
14.0
24.8
42
30
L02AE02
ATC
leuprorelin; implant, parenteral
3.7
24.0
105
283
8520/3-C50.8
ICD-O-3
Lobular carcinoma, NOS, of overlapping lesion of breast
+∞
24.0
23
*
394
Kela drug reimbursment
Palbociclib
+∞
24.0
23
*
8500/2-C50.2
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-inner quadrant of breast
+∞
24.0
23
*
1501
Kela drug reimbursment
Palbociclib
+∞
24.0
23
*
8500/2-C50.3
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of lower-inner quadrant of breast
+∞
24.0
23
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.9
23.9
149
519
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.4
23.9
202
841
PJ1AN
NOMESCO Finland
Lymphsystem isotope imaging
20.6
23.8
35
17
1XC13
NOMESCO Finland
NA
240.4
23.6
24
*
TQW99
NOMESCO Finland
Other minor procedure on skin
1.9
23.5
374
2046
8543/3-C50.9
ICD-O-3
Paget disease and intraductal carcinoma of breast of breast, NOS
+∞
22.9
22
*
C507
ICD-10 Finland
NA
+∞
22.9
22
*
PJ5YQ
NOMESCO Finland
NA
+∞
22.9
22
*
N60.9
ICD-10 Finland
Benign mammary dysplasia, unspecified
4.5
22.9
82
184
HAD55
NOMESCO Finland
Incision of periprosthetic capsule of breast
83.6
22.6
25
*
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.8
22.4
96
255
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
10.5
22.2
43
41
SPAT1324
SPAT
Screening procedure
0.7
22.1
913
12340
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
62.6
21.8
25
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
21.7
444
2631
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
4.7
21.7
74
158
N64.8
ICD-10 Finland
Other specified disorders of breast
4.8
21.3
71
148
OAA41
NOMESCO Finland
Health check based on individual needs
17.4
21.3
33
19
B01AB10
ATC
tinzaparin; parenteral
1.6
21.2
524
3277
8480/3-C50.4
ICD-O-3
Mucinous adenocarcinoma of upper-outer quadrant of breast
+∞
20.8
20
*
8401/3-C50.9
ICD-O-3
Apocrine adenocarcinoma of breast, NOS
+∞
20.8
20
*
8575/3-C50.9
ICD-O-3
Metaplastic carcinoma, NOS, of breast, NOS
+∞
20.8
20
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
3.4
20.3
101
303
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.7
20.3
142
534
8530/3-C50.9
ICD-O-3
Inflammatory carcinoma of breast, NOS
+∞
19.8
19
*
ZZQ70
NOMESCO Finland
Free microvascular graft of lymph nodes
+∞
19.8
19
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
3.6
19.6
88
244
C50.61
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, ductal tumor
200.3
19.5
20
*
ZSZ10
NOMESCO Finland
Secondary repair operation
34.3
18.9
24
7
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
4.0
18.8
76
193
HAF00
NOMESCO Finland
Excision of local recurrence of breast cancer
+∞
18.7
18
*
8211/3-C50.2
ICD-O-3
Tubular adenocarcinoma of upper-inner quadrant of breast
+∞
18.7
18
*
WX400
NOMESCO Finland
Inhalation anesthesy
1.9
18.7
297
1627
S18
ICPC
Laceration/cut
1.2
18.6
3122
27059
HAD10
NOMESCO Finland
Augmentation of breast using prosthesis
6.6
18.3
47
72
Y83.4
ICD-10 Finland
Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
11.0
18.1
34
31
C49.39
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor
32.9
17.9
23
7
103
Kela drug reimbursment
Diabetes, insulin-treated
0.8
17.9
1143
14531
8401/3-C50.4
ICD-O-3
Apocrine adenocarcinoma of upper-outer quadrant of breast
+∞
17.7
17
*
T85.4
ICD-10 Finland
Mechanical complication of breast prosthesis and implant
8.3
17.4
38
46
A46
ICD-10 Finland
Erysipelas
1.4
17.1
835
6079
N02AA05
ATC
oxycodone; systemic
1.4
17.0
990
7427
JN4CD
NOMESCO Finland
Very extensive body CT
1.9
17.0
237
1241
HAB30
NOMESCO Finland
Excision of mamilla or areola
19.3
16.8
25
13
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.8
16.8
1018
13043
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
2.9
16.7
103
361
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.7
16.7
484
6970
335
Kela drug reimbursment
Lapatinib
+∞
16.7
16
*
8510/3-C50.4
ICD-O-3
Medullary carcinoma, NOS, of upper-outer quadrant of breast
+∞
16.7
16
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
7.6
16.5
38
50
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.1
16.5
178
840
SPAT1269
SPAT
Other puncture and/or drainage
4.2
16.5
62
148
ZXC90
NOMESCO Finland
Use of absorbable mesh in surgery
170.2
16.5
17
*
ZSP00
NOMESCO Finland
Procedure related to previous procedure classified in chapter P
27.5
16.5
22
8
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.4
16.1
77
226
X79
ICPC
Benign neoplasm breast female
13.5
15.9
27
20
HA1AT
SPAT
NA
12.2
15.8
28
23
ZZS50
NOMESCO Finland
Insertion of tissue expander
60.1
15.7
18
*
HAB20
NOMESCO Finland
Excision of lactiferous duct
5.0
15.7
50
101
8520/3-C50.3
ICD-O-3
Lobular carcinoma, NOS, of lower-inner quadrant of breast
+∞
15.6
15
*
8575/3-C50.4
ICD-O-3
Metaplastic carcinoma, NOS, of upper-outer quadrant of breast
+∞
15.6
15
*
8500/2-C50.1
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of central portion of breast
+∞
15.6
15
*
8507/3-C50.9
ICD-O-3
Invasive micropapillary carcinoma of breast of breast, NOS
+∞
15.6
15
*
HA1DM
NOMESCO Finland
Mammary gland very extensive MRI examination with 3 Tesla magnet
38.1
15.4
19
5
6117B
ICD-9 Finland
Other disorders of breast, Signs and symptoms in breast[TUMOR MAMMAE]
3.3
15.1
76
233
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.6
15.1
107
410
J01DB01
ATC
cefalexin; oral
1.2
15.0
6473
61105
I10
ICD-10 Finland
Essential (primary) hypertension
0.8
15.0
3898
42871
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.5
14.8
468
3114
HA5CB
NOMESCO Finland
Galactography
6.0
14.7
40
67
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
16.5
14.7
23
14
A10BA02
ATC
metformin; oral
0.8
14.7
1252
15390
9020/3-C50.9
ICD-O-3
Phyllodes tumor, malignant of breast, NOS
+∞
14.6
14
*
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
5.7
14.6
41
72
ZZS55
NOMESCO Finland
Distension of tissue expander
80.2
14.6
16
*
Z51.5
ICD-10 Finland
Palliative care
1.6
14.5
342
2116
9729
FHL
Other measure in this category
5.0
14.5
46
93
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
14.3
173
856
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.4
14.3
125
535
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.2
14.0
139
634
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
13.9
183
941
M05BA02
ATC
clodronic acid; systemic
6.8
13.9
34
50
PG1BD
NOMESCO Finland
Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft
53.4
13.8
16
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
13.7
1361
11019
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
0.7
13.6
515
7093
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.5
13.6
403
2645
8522/3-C50.5
ICD-O-3
Infiltrating duct and lobular carcinoma of lower-outer quadrant of breast
+∞
13.5
13
*
1744A
ICD-10 Finland
NA
+∞
13.5
13
*
8504/2-C50.9
ICD-O-3
Encapsulated papillary carcinoma of breast, NOS
+∞
13.5
13
*
8522/3-C50.2
ICD-O-3
Infiltrating duct and lobular carcinoma of upper-inner quadrant of breast
+∞
13.5
13
*
QBA10
NOMESCO Finland
Incision of skin of trunk
3.2
13.5
70
220
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
0.8
13.5
1006
12585
C50.02
ICD-10 Finland
Malignant tumor of nipple and areola, lobular tumor
140.1
13.4
14
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.4
13.4
601
4304
M05BX04
ATC
denosumab; parenteral
1.5
13.4
405
2667
SPAT1152
SPAT
Removal of foreign body from under the skin
1.9
13.4
185
968
J01MA12
ATC
levofloxacin; systemic
1.3
13.2
1152
9169
B29
ICPC
Lymph/immune mech sympt/complt other
4.6
13.2
45
99
-1
ICD-10 Finland
NA
1.8
13.1
226
1279
TPX10
NOMESCO Finland
Implantation of vascular injection port
1.9
13.0
178
926
T90
ICPC
Diabetes non-insulin dependent
0.8
13.0
1006
12528
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
8.3
13.0
28
34
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
9.3
12.9
26
28
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.1
12.9
151
740
QWF00
NOMESCO Finland
Reoperation for insufficiency of suture in plastic surgery of skin
22.5
12.9
18
8
WB600
NOMESCO Finland
Neoadjuvant therapy of primary tumour with antibodies
50.0
12.8
15
*
2170A
ICD-9 Finland
Benign neoplasm of breast[NEOPLASMA BENIGNUM MAMMAE]
2.9
12.8
77
269
HA1AA
SPAT
NA
2.2
12.7
133
622
X18
ICPC
Breast pain female
2.2
12.6
125
571
THA00
NOMESCO Finland
Needle biopsy of mamilla
6.8
12.6
31
46
L01EF01
ATC
palbociclib; oral
+∞
12.5
12
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
12.5
1331
10864
WW500
NOMESCO Finland
Blood transfusion
1.7
12.5
240
1402
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.3
12.2
106
455
N05CF01
ATC
zopiclone; oral
1.2
12.1
2556
22425
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
3.3
11.9
59
181
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.6
11.8
302
1911
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.2
11.5
116
534
8543/3-C50.1
ICD-O-3
Paget disease and intraductal carcinoma of breast of central portion of breast
+∞
11.5
11
*
9680/3-C50.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of breast, NOS
+∞
11.5
11
*
1XC14
NOMESCO Finland
NA
+∞
11.5
11
*
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
11.8
11.3
20
17
ZZR70
NOMESCO Finland
Perforator flaps
35.0
11.2
14
*
QCJ00
NOMESCO Finland
Liposuction in upper limb
17.0
11.2
17
10
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
11.1
7259
69879
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.7
11.0
242
1475
WF004
NOMESCO Finland
Palliative radiotherapy
2.3
10.8
94
406
8097/3-C44.3
ICD-O-3
Basal cell carcinoma, nodular of skin of other and unspecified parts of face
15.5
10.8
17
11
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
0.7
10.8
398
5506
HAD57
NOMESCO Finland
Resection of periprosthetic capsule of breast
21.4
10.7
15
7
Z44.3
ICD-10 Finland
Fitting and adjustment of external breast prosthesis
60.0
10.6
12
*
HAA01
NOMESCO Finland
Suture of mammary gland
60.0
10.6
12
*
HAC99
NOMESCO Finland
Other mastectomy
60.0
10.6
12
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.4
10.6
492
3546
A04AA03
ATC
tropisetron; systemic
4.2
10.6
39
94
JN6AD
NOMESCO Finland
CT of torso and neck
2.5
10.5
78
308
N05BA04
ATC
oxazepam; oral
1.2
10.5
1904
16430
WX704
NOMESCO Finland
Intubation
1.4
10.4
433
3055
9829
FHL
Other measure in this category
+∞
10.4
10
*
ZZQ60
NOMESCO Finland
Free microvascular graft of nerve
+∞
10.4
10
*
8507/3-C50.4
ICD-O-3
Invasive micropapillary carcinoma of breast of upper-outer quadrant of breast
+∞
10.4
10
*
8524/3-C50.9
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of breast, NOS
+∞
10.4
10
*
QBJ99
NOMESCO Finland
Other aesthetic correction of skin of trunk
16.0
10.3
16
10
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.0
10.2
118
580
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.9
10.2
5007
53175
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
0.8
10.2
1499
17495
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
10.2
1700
14544
TPH07
NOMESCO Finland
Cathetrisation of artery
1.4
10.1
603
4541
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
1.4
10.0
492
3586
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
2.6
9.9
68
261
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
3.5
9.8
44
126
WW200
SPAT
NA
0.7
9.7
379
5190
SAA01
NOMESCO Finland
Simple examination of mouth
0.9
9.5
4647
49502
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
2.0
9.5
114
570
D70.89
ICD-10 Finland
Neutropenic splenomegaly
2.4
9.4
78
329
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
3.3
9.4
45
136
9710
FHL
Existence of a relapse
100.1
9.4
10
*
C50.69
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, other or undeterminated histology
100.1
9.4
10
*
JN5AN
NOMESCO Finland
Total body isotope imaging
17.5
9.4
14
8
8540/3-C50.0
ICD-O-3
Paget disease, mammary of nipple
+∞
9.4
9
*
N60.1
ICD-10 Finland
Diffuse cystic mastopathy
2.3
9.3
81
352
205
Kela drug reimbursment
Chronic hypertension
0.8
9.3
1489
17254
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.7
9.1
59
219
GD1AD
NOMESCO Finland
Thorax CT examination
1.6
9.1
232
1474
E66.01
ICD-10 Finland
Obesity due to excess calories
0.7
9.0
254
3673
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.3
9.0
540
4069
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.9
8.9
3212
34988
C08CA01
ATC
amlodipine; oral
0.9
8.8
2103
23608
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
8.6
8.8
18
21
ZXC82
NOMESCO Finland
Microsurgical
10.7
8.8
16
15
L02AE03
ATC
goserelin; implant
2.7
8.8
58
219
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
2.5
8.7
63
249
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
0.9
8.6
3520
38061
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
2.1
8.6
91
433
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
5.8
8.6
23
40
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.4
8.6
477
3553
C10AA01
ATC
simvastatin; oral
0.9
8.6
2652
29222
9705
FHL
Subcutaneous mastectomy
11.5
8.5
15
13
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.6
8.5
187
1143
SPAT1262
SPAT
Handing over of treatment supplies
0.8
8.5
770
9451
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
0.7
8.4
286
4008
QBE35
NOMESCO Finland
Repair of skin defect in trunk after surgery or injury
6.0
8.4
22
37
9120/3-C50.9
ICD-O-3
Hemangiosarcoma of breast, NOS
+∞
8.3
8
*
8501/2-C50.9
ICD-O-3
Comedocarcinoma, noninfiltrating of breast, NOS
+∞
8.3
8
*
8480/3-C50.3
ICD-O-3
Mucinous adenocarcinoma of lower-inner quadrant of breast
+∞
8.3
8
*
8500/2-C50.8
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of overlapping lesion of breast
+∞
8.3
8
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
0.7
8.3
293
4080
A10AE04
ATC
insulin glargine; parenteral
0.7
8.1
264
3725
N81.1
ICD-10 Finland
Cystocele
0.8
8.1
444
5790
XX9CN
NOMESCO Finland
NA
22.0
8.0
11
5
C49.30
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax without histology
22.0
8.0
11
5
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
0.9
8.0
2903
31680
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
4.1
7.9
29
71
E66.8
ICD-10 Finland
Other obesity
0.6
7.9
153
2380
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.3
7.8
483
3657
XX9KE
NOMESCO Finland
Ultrasound examination with contrast
10.8
7.8
14
13
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
6.9
7.7
18
26
PD2BD
NOMESCO Finland
Extensive CT angiography of pelvic organs
18.3
7.6
11
6
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
8.0
7.6
16
20
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
3.4
7.5
34
100
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.3
7.5
444
3344
9822
FHL
Myocutaneous graft
80.1
7.4
8
*
1746A
ICD-9 Finland
Malignant neoplasm of female breast, Axillary tail
80.1
7.4
8
*
8097/3-C44.5
ICD-O-3
Basal cell carcinoma, nodular of skin of trunk
80.1
7.4
8
*
SDA02
NOMESCO Finland
Parodonthologic therapy
0.9
7.4
1899
21254
WF099
NOMESCO Finland
Other radiotherapy
3.1
7.4
38
124
8480/3-C50.2
ICD-O-3
Mucinous adenocarcinoma of upper-inner quadrant of breast
+∞
7.3
7
*
L01EH01
ATC
lapatinib; oral
+∞
7.3
7
*
8509/2-C50.9
ICD-O-3
Solid papillary carcinoma in situ of breast, NOS
+∞
7.3
7
*
8523/3-C50.5
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of lower-outer quadrant of breast
+∞
7.3
7
*
8503/2-C50.4
ICD-O-3
Noninfiltrating intraductal papillary adenocarcinoma of upper-outer quadrant of breast
+∞
7.3
7
*
8480/3-C50.5
ICD-O-3
Mucinous adenocarcinoma of lower-outer quadrant of breast
+∞
7.3
7
*
Y16
ICPC
Breast symptom/complaint male
+∞
7.3
7
*
8010/3-C50.4
ICD-O-3
Carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
8200/3-C50.9
ICD-O-3
Adenoid cystic carcinoma of breast, NOS
+∞
7.3
7
*
8503/3-C50.4
ICD-O-3
Intraductal papillary adenocarcinoma with invasion of upper-outer quadrant of breast
+∞
7.3
7
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
1.6
7.3
164
1014
6101A
ICD-9 Finland
Benign mammary dysplasias, Diffuse cystic mastopathy
2.5
7.2
52
208
A21
ICPC
Risk factor for malignancy
5.4
7.2
20
37
SDA01
NOMESCO Finland
Simple parodonthologic therapy
0.8
7.2
1341
15380
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.3
7.2
442
3351
A26
ICPC
Fear of cancer, NOS
2.7
7.2
44
161
9722
FHL
Reduction plastic and possible mamilla transposition
3.0
7.1
38
127
N06AB05
ATC
paroxetine; oral
1.4
7.1
376
2785
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
0.7
7.1
215
3066
OAB47
SPAT
NA
0.5
7.0
42
896
R06AE07
ATC
cetirizine; oral
1.1
7.0
3411
31552
G03FA14
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.8
6.9
370
4842
TQX05
NOMESCO Finland
Skin puncture, unspecified location
4.4
6.9
23
52
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.8
6.9
1276
14646
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.2
6.8
9
374
9844
FHL
Musculocutaneous tongue
39.9
6.7
8
*
M70.6
ICD-10 Finland
Trochanteric bursitis
0.8
6.7
832
9897
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
2.7
6.7
44
166
A87
ICPC
Complication of medical treatment
2.4
6.7
52
217
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.3
6.6
526
4130
GA5AA
NOMESCO Finland
Rib X-ray examination
3.5
6.6
28
79
P01BA02
ATC
hydroxychloroquine; oral
0.8
6.6
442
5611
L17
ICPC
Foot/toe symptom/complaint
0.9
6.5
1491
16839
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
2.8
6.4
39
142
G47.3
ICD-10 Finland
Sleep apnoea
0.8
6.4
781
9307
SAA02
NOMESCO Finland
Basic examination of mouth
0.9
6.4
4135
43809
KMAK
NOMESCO Finland
NA
0.9
6.4
3177
34163
HA1DT
NOMESCO Finland
Mammary gland biopsy with MRI guidance
69.8
6.4
7
*
L03
ICPC
Low back symptom/complaint
0.9
6.4
1421
16091
SPAT1310
SPAT
Counselling related to known health issue
0.9
6.4
1869
20759
L88
ICPC
Rheumatoid/seropositive arthritis
0.7
6.3
148
2215
K02.1
ICD-10 Finland
Caries of dentine
0.9
6.3
3335
35741
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
0.5
6.3
56
1053
C05.1
ICD-10 Finland
Malignant neoplasm: Soft palate
9.2
6.3
12
13
6119X
ICD-9 Finland
Other disorders of breast, Unspecified breast disorder
9.2
6.3
12
13
8541/3-C50.9
ICD-O-3
Paget disease and infiltrating duct carcinoma of breast of breast, NOS
+∞
6.2
6
*
L01EF03
ATC
abemaciclib; oral
+∞
6.2
6
*
8201/3-C50.4
ICD-O-3
Cribriform carcinoma, NOS, of upper-outer quadrant of breast
+∞
6.2
6
*
8211/3-C50.5
ICD-O-3
Tubular adenocarcinoma of lower-outer quadrant of breast
+∞
6.2
6
*
3030
Kela drug reimbursment
Abemaciclib
+∞
6.2
6
*
173
Kela drug reimbursment
Trastuzumab injection
+∞
6.2
6
*
8010/2-C50.9
ICD-O-3
Carcinoma in situ, NOS, of breast, NOS
+∞
6.2
6
*
1515
Kela drug reimbursment
NA
+∞
6.2
6
*
8201/3-C50.9
ICD-O-3
Cribriform carcinoma, NOS, of breast, NOS
+∞
6.2
6
*
8522/3-C50.8
ICD-O-3
Infiltrating duct and lobular carcinoma of overlapping lesion of breast
+∞
6.2
6
*
8480/3-C50.1
ICD-O-3
Mucinous adenocarcinoma of central portion of breast
+∞
6.2
6
*
8507/3-C50.2
ICD-O-3
Invasive micropapillary carcinoma of breast of upper-inner quadrant of breast
+∞
6.2
6
*
21799
ICD-8 Finland
Benign neoplasm of breast
1.9
6.2
86
459
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
1.6
6.2
135
831
N81.6
ICD-10 Finland
Rectocele
0.8
6.2
445
5600
L03.3
ICD-10 Finland
Cellulitis of trunk
2.5
6.2
44
175
A14AB01
ATC
nandrolone; parenteral
3.9
6.2
23
59
A10BH01
ATC
sitagliptin; oral
0.8
6.1
339
4410
EBA00
NOMESCO Finland
Extraction of tooth
0.9
6.1
1605
17970
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
1.8
6.1
89
483
K85
ICPC
Elevated blood pressure
0.8
6.1
834
9827
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
0.7
6.1
248
3368
N60.0
ICD-10 Finland
Solitary cyst of breast
2.2
6.0
55
248
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1617658) Protocol used for examination of sentinel lymph nodes
624
87
77.21
307.65
1.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
324
165
20.35
307.65
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
1656
991
20.46
307.65
1.4
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
648
335
20.82
307.65
3.1
1.3
u/ml
30.7
41.3
0.86
640
325
(3002256) Pathology report gross observation
2126
8632
2.94
307.65
1.3
1.2
—
—
—
0
0
(4035726)
2343
5316
5.69
307.65
1.4
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
1119
517
24.72
307.65
3.4
1.3
u/ml
31.6
30.6
0.08
1083
489
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
5349
37798
2.10
229.07
7.8
5.3
umol/l
10.0
10.6
3.96
5125
35383
(40768795) Lymph node Pathology biopsy report
362
584
6.42
214.24
1.1
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
4069
26836
1.98
201.29
4.7
2.8
mmol/l
2.4
2.4
16.91
3636
22605
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
7095
57219
2.40
200.88
9.6
6.9
u/l
80.0
78.8
1.17
6777
53034
(3044640) Blood type and Crossmatch panel - Blood
3564
22516
2.00
198.95
2.3
2.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
5493
41161
1.93
175.28
10.7
8.6
e9/l
3.7
4.1
35.12
4918
35339
(40758558) Short blood count panel - Blood
2931
17904
1.97
174.82
7.7
6.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
4436
31129
1.88
172.29
2.4
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
4649
33145
1.88
171.43
3.8
3.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1562
7690
2.26
164.51
3.4
3.7
ug/l
14.3
20.3
0.71
1179
6178
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
542
1733
3.27
133.80
1.2
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
201
400
5.12
94.89
1.2
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2545
17312
1.67
92.60
2.2
2.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1138
6611
1.83
70.38
1.7
2.1
g/l
0.2
0.2
15.09
1093
6110
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
4291
35845
1.39
47.77
5.2
5.3
mmol/l
1.2
1.2
4.24
3866
31865
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
4633
39597
1.37
42.64
6.0
5.9
mmol/l
1.2
1.2
2.12
3798
33178
(3023368) Bacteria identified in Blood by Culture
2381
18281
1.42
42.01
4.1
4.1
—
—
—
0
0
(40758358) Immune stain study
31
16
19.42
39.65
1.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
2226
17129
1.40
38.03
1.4
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
892
5942
1.56
31.29
3.5
3.7
u/ml
94.2
61.6
0.47
874
5711
(3042936) Bacteria identified in Isolate by Culture
1311
9485
1.45
30.75
1.9
1.9
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
3861
33515
1.27
25.74
4.0
4.4
g/l
35.4
35.4
0.09
3553
30739
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1033
7387
1.45
25.42
3.3
3.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
2268
18413
1.31
25.33
3.5
3.6
%
94.2
93.6
0.60
2222
17885
(3018418) pH of Serum or Plasma
2857
23978
1.29
24.66
3.8
3.7
ph
7.4
7.4
1.67
588
4144
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
256
1313
1.98
22.73
1.3
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
151
637
2.39
21.95
1.3
1.3
nmol/l
0.3
0.4
0.49
94
449
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
7240
68611
1.35
21.47
16.1
13.3
ml/min/173m2
79.1
76.6
23.96
6333
55595
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
182
873
2.11
19.46
1.2
1.2
u/l
57.1
58.1
0.13
123
597
(3020682) Albumin/Creatinine [Ratio] in Urine
1924
23091
0.78
18.75
3.6
3.8
mg/mmol
5.8
7.5
1.33
986
13023
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
6506
68489
0.79
18.49
5.4
6.0
mmol/mol
39.2
39.8
8.05
5801
62621
(3012516) Albumin [Mass/volume] in Urine
1826
21974
0.78
18.04
2.9
3.1
mg/l
452.6
489.4
0.10
936
12309
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
7095
73783
0.77
17.20
5.0
5.2
mmol/l
2.9
2.8
2.19
6283
67113
(3009508) Creatinine [Moles/volume] in Urine
1901
22654
0.79
17.07
2.9
3.0
mmol/l
6.1
6.2
0.28
1512
18788
(3019225) pH of Specimen
1067
8200
1.34
16.70
4.2
4.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
6574
68943
0.80
16.61
3.9
4.1
mmol/l
1.2
1.3
6.99
5739
61930
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
6934
72140
0.79
15.20
4.4
4.6
mmol/l
4.9
4.9
6.97
6162
65876
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
168
891
1.90
13.68
1.3
1.4
u/l
37.2
38.6
0.19
156
692
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
6883
71520
0.80
13.65
4.4
4.6
mmol/l
1.6
1.6
12.74
6085
64913
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
112
516
2.18
13.42
1.3
1.2
u/l
19.6
23.0
0.28
96
433
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
113
524
2.17
13.32
1.3
1.2
u/l
64.6
82.3
1.93
102
453
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
88
367
2.41
13.30
1.8
1.7
ug/l
1.6
6.2
1.85
62
245
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1449
11942
1.26
13.07
3.0
2.9
mmol/l
0.8
0.8
1.63
1338
10939
(3013512) EKG study
2568
22554
1.20
12.27
3.8
4.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1414
16801
0.81
11.50
4.7
4.8
kg/l
1.0
1.0
0.13
218
2582
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
827
6452
1.31
11.48
3.5
3.3
mmol/l
1.2
1.2
0.95
737
5436
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
246
1567
1.59
10.50
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
246
1567
1.59
10.50
1.3
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
282
1861
1.53
10.31
1.7
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1396
11740
1.22
10.23
1.9
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2561
22791
1.17
10.04
3.6
3.0
u/l
34.3
32.8
0.18
2429
21465
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
239
1530
1.58
10.01
1.6
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1814
15711
1.19
9.73
3.1
3.0
mmol/l
2.5
2.5
2.65
1598
13635
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
183
1114
1.66
9.44
1.7
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
5518
52205
1.16
9.17
3.9
3.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3792
34991
1.15
8.83
2.2
2.3
nmol/l
81.6
80.6
1.21
3310
30835
(3013826) Glucose [Moles/volume] in Serum or Plasma
4589
42937
1.15
8.66
4.2
4.3
mmol/l
6.5
6.7
8.96
4329
40082
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
275
1875
1.48
8.66
1.6
2.0
%
95.2
93.8
0.44
258
1724
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
140
817
1.72
8.50
1.4
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
225
1478
1.53
8.47
1.6
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
78
385
2.03
8.00
2.5
3.6
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
97
517
1.88
7.97
1.8
1.5
u/l
6.6
6.6
0.00
53
242
(3019550) Sodium [Moles/volume] in Serum or Plasma
7770
75879
1.25
7.95
17.8
16.7
mmol/l
139.6
139.7
1.27
7557
73842
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
7450
72445
1.21
7.91
16.3
14.4
mg/l
22.5
21.8
0.97
6033
57215
(42870588) Differential panel, method unspecified - Blood
2773
25188
1.15
7.82
5.0
6.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
121
695
1.75
7.80
1.3
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
3472
32040
1.14
7.71
10.2
9.5
e9/l
0.0
0.0
0.88
2776
26139
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
257
1772
1.46
7.69
1.9
2.2
%
201.3
192.4
0.83
247
1670
(3003434) Protein [Mass/volume] in Pleural fluid
130
769
1.70
7.56
1.3
1.4
g/l
33.2
32.1
0.49
117
692
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
78
398
1.97
7.33
1.1
1.1
u/l
15.2
24.2
1.65
62
294
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
78
400
1.96
7.23
1.1
1.1
u/l
75.5
80.7
0.32
65
305
(3002030) Lymphocytes/100 leukocytes in Blood
3758
34951
1.13
7.22
5.3
6.3
%
26.9
28.5
14.34
3455
32125
(3023103) Potassium [Moles/volume] in Serum or Plasma
7775
76047
1.23
7.09
17.9
16.8
mmol/l
3.9
3.9
4.04
7550
73858
(3032080) INR in Blood by Coagulation assay
3207
29555
1.13
7.09
7.5
8.2
inr
1.3
1.2
0.22
961
8161
(40768806) Pleura Pathology biopsy report
105
604
1.75
6.80
1.5
1.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
3676
34227
1.13
6.79
5.4
6.5
%
8.8
8.4
6.56
3398
31644
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1531
17305
0.86
6.63
1.7
1.7
pmol/l
55285704.6
31229010.9
0.65
1192
13984
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
247
1744
1.43
6.57
1.9
2.4
g/l
3.7
3.6
0.37
239
1646
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1216
13974
0.85
6.48
1.3
1.3
u/ml
11.2
14.9
1.14
427
5152
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
7046
72175
0.86
6.35
4.7
4.8
mmol/l
5.8
5.9
5.59
6237
65231
(3022096) Basophils/100 leukocytes in Blood
3551
33087
1.12
6.33
5.2
6.2
%
0.7
0.7
1.77
3270
30435
(3007853) Bacteria identified in Skin by Aerobe culture
985
8377
1.20
6.29
1.7
1.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
3646
34043
1.12
6.24
5.2
6.2
%
2.7
2.8
4.35
3354
31318
(3018010) Neutrophils/100 leukocytes in Blood
3691
34516
1.12
6.10
5.1
6.0
%
57.7
57.0
2.59
3399
31847
(3028308) Erythrocytes [#/volume] in Pleural fluid
106
637
1.67
5.91
1.4
1.4
e6/l
43812.1
57816.4
0.22
55
366
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
89
1497
0.59
5.86
2.5
2.4
ug/min
151.3
61.9
0.93
48
827
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
357
2734
1.32
5.77
1.9
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
539
6616
0.80
5.74
3.8
3.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
99
590
1.68
5.71
1.4
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
385
2985
1.30
5.69
2.1
2.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1288
14580
0.86
5.59
1.3
1.3
iu/ml
35.3
38.5
0.31
394
4731
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1545
17254
0.87
5.54
1.3
1.3
u/ml
1.9
1.5
0.32
347
4508
(3023199) Leukocytes [#/volume] in Pleural fluid
113
704
1.61
5.50
1.4
1.4
e6/l
3005.0
2214.0
0.32
80
515
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
6879
70445
0.88
5.46
5.5
5.6
mu/l
1.9
2.1
2.12
6159
64344
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2655
28646
0.89
5.45
4.4
4.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
229
1656
1.39
5.39
1.1
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
945
8128
1.18
5.30
1.7
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1797
16225
1.13
5.19
1.4
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
541
4426
1.24
5.14
1.7
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
64
349
1.84
5.05
2.2
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
64
349
1.84
5.05
2.2
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
64
349
1.84
5.05
2.2
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
342
4360
0.77
5.05
1.3
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
7835
76994
1.20
4.98
13.2
10.6
u/l
24.1
23.6
1.18
7562
73727
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
64
351
1.83
4.97
2.2
1.5
—
—
—
0
0
(3036489) Thrombin time
318
2455
1.31
4.90
1.6
1.8
s
21.4
21.3
0.13
287
2132
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
5996
61802
0.90
4.90
4.6
4.7
pmol/l
15.0
14.9
0.48
5341
56051
(3052851) Hemolysis interference index of Serum or Plasma
300
2302
1.31
4.84
2.9
3.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
938
8135
1.17
4.76
1.7
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
6105
59086
1.11
4.65
20.7
17.4
%
13.8
13.8
0.17
5997
57735
(36304419) Bacteria [Presence] in Urine
2155
19786
1.12
4.64
2.9
3.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
153
2169
0.70
4.62
1.5
1.6
iu/ml
10.6
2.2
0.37
31
473
(3045788) Cell count panel - Pleural fluid
89
548
1.63
4.61
1.5
1.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
22
81
2.72
4.49
1.4
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
53
285
1.86
4.42
2.4
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
52
279
1.87
4.37
2.4
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
52
279
1.87
4.37
2.4
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
77
1236
0.62
4.30
1.3
1.7
nmol/l
0.8
0.8
0.15
54
1018
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
430
3504
1.24
4.29
7.6
7.7
mmol/l
24.7
24.6
0.34
407
3256
(3026493) Urate [Moles/volume] in Serum or Plasma
1683
18424
0.89
4.27
2.5
2.4
umol/l
6634.3
4792.8
0.87
1405
15505
(3035350) Ketones [Presence] in Urine by Test strip
3581
37722
0.91
4.27
4.0
4.2
estimate
0.0
0.0
0.43
673
6632
(3019832) Treponema pallidum Ab [Presence] in Serum
226
2966
0.75
4.21
1.4
1.5
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
29
128
2.27
4.10
1.1
1.3
ug/l
713.8
104.0
0.48
16
79
(3048689) Calprotectin [Mass/mass] in Stool
825
9436
0.86
4.08
1.8
2.0
ug/g
136.9
129.8
0.09
608
7200
(3029937) Albumin [Presence] in Urine by Test strip
1880
20360
0.90
3.88
4.6
4.7
estimate
0.0
0.0
2.12
658
6659
(3015171) Extractable nuclear Ab [Units/volume] in Serum
274
3465
0.78
3.86
1.3
1.3
u/ml
2.6
1.1
0.49
25
325
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
124
860
1.45
3.81
1.3
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1267
11400
1.13
3.81
2.6
2.8
e6/l
4.3
4.6
0.24
641
5867
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
53
302
1.76
3.73
2.5
3.3
—
—
—
0
0
(4034850)
201
2628
0.76
3.69
12.4
9.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
76
479
1.59
3.67
1.4
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
118
820
1.44
3.61
2.7
3.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
3670
38409
0.92
3.52
4.1
4.3
estimate
0.0
0.0
2.04
679
6714
(3021601) Nitrite [Presence] in Urine by Test strip
3634
38037
0.92
3.48
5.4
5.6
estimate
0.0
0.0
1.60
663
6636
(3030467) Casts [#/volume] in Urine by Automated count
2180
20296
1.10
3.45
2.9
3.1
e6/l
0.4
0.4
0.25
1598
15054
(3022475) Manganese [Moles/volume] in Blood
15
52
2.88
3.45
1.1
1.2
—
—
—
0
0
(4010399)
503
5895
0.84
3.40
1.4
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
94
634
1.49
3.38
1.9
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
134
1833
0.73
3.37
1.6
1.8
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
18
70
2.57
3.37
1.8
2.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
678
5901
1.16
3.34
3.4
2.6
ml/min/173m2
64.7
62.4
1.06
268
2408
(3013139) Helicobacter pylori Ag [Presence] in Stool
502
5873
0.84
3.33
1.2
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
1542
14149
1.11
3.26
2.5
2.8
mosm/kgh2o
495.7
500.7
0.43
1278
11890
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
79
519
1.53
3.23
1.4
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1752
18878
0.91
3.20
3.9
4.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
704
6168
1.15
3.18
4.3
4.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
889
7920
1.14
3.14
4.3
4.1
u/l
252.0
246.6
0.50
827
7417
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
277
2234
1.25
3.13
2.3
2.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
181
1384
1.31
3.13
1.2
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
970
10773
0.89
3.11
1.3
1.4
titre
483.6
591.8
1.37
234
2560
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
85
574
1.48
3.07
2.0
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
85
574
1.48
3.07
2.0
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
85
574
1.48
3.07
2.0
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
194
2479
0.78
3.05
1.6
1.6
titre
145.5
296.1
1.95
11
129
(3003338) MCHC [Mass/volume]
5803
59458
0.92
3.04
22.2
19.1
g/l
329.7
330.1
2.49
5758
58998
(3000570) Elastase.pancreatic [Mass/mass] in Stool
205
2600
0.78
3.04
1.3
1.4
ug/g
284.5
282.4
0.05
110
1499
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
174
2250
0.77
3.01
1.3
1.3
u/ml
3.1
4.8
0.39
20
268
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
54
858
0.63
3.01
1.1
1.1
iu/ml
19.7
14191.4
0.55
15
168
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
673
5906
1.15
2.99
1.6
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
6527
63819
1.09
2.98
18.2
15.9
%
38.3
38.5
1.48
4540
42955
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
177
2278
0.77
2.96
1.3
1.3
u/ml
9.9
5.5
0.42
31
420
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
18
75
2.40
2.95
1.8
2.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
143
1068
1.34
2.94
2.1
2.1
mg/l
26.7
26.5
0.01
43
289
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
202
2550
0.79
2.90
1.6
1.8
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
682
6009
1.15
2.87
5.8
5.8
mmol/l
1.3
1.3
0.47
658
5812
(44790047)
97
682
1.43
2.87
1.3
1.4
—
—
—
0
0
(44806118)
97
682
1.43
2.87
1.3
1.4
—
—
—
0
0
(44790048)
97
682
1.43
2.87
1.3
1.4
—
—
—
0
0
(44790049)
97
682
1.43
2.87
1.3
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
98
691
1.42
2.86
1.9
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
95
670
1.42
2.77
1.1
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
116
847
1.37
2.77
1.5
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
232
2865
0.80
2.76
1.5
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
337
2818
1.20
2.73
1.4
1.3
iu/l
46.1
37.4
4.04
287
2461
(40761511) CBC panel - Blood by Automated count
7585
74773
1.12
2.72
15.3
13.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
3018
31603
0.93
2.71
2.6
2.8
ug/l
122.9
109.0
1.77
2688
28894
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
15
339
0.44
2.70
1.3
1.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
145
1890
0.76
2.70
1.3
1.3
u/ml
1.1
5.2
2.07
12
147
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1179
10786
1.11
2.65
1.9
2.0
s
29.4
29.4
0.02
1139
10449
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
73
1057
0.69
2.64
1.2
1.2
u/l
30.5
33.3
0.14
63
912
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
72
1044
0.69
2.63
1.2
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
395
3366
1.18
2.60
1.3
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2267
23959
0.93
2.58
1.9
2.1
u/l
146.2
170.9
1.40
2104
22237
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
200
2485
0.80
2.54
1.3
1.3
u/ml
35.1
43.8
0.16
13
175
(3002582) Erythrocytes [#/volume] in Urine
2306
21770
1.08
2.54
3.0
3.2
e6/l
122.0
65.2
0.68
1691
16260
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
195
2415
0.80
2.43
1.3
1.7
g/l
1.2
1.2
0.55
188
2275
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
65
0.00
2.41
0.0
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
190
2350
0.80
2.35
1.3
1.7
g/l
0.2
0.2
0.27
182
2203
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
68
468
1.46
2.32
1.8
1.7
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
9
217
0.41
2.29
1.4
1.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
59
862
0.68
2.29
1.2
1.2
mmol/l
7.3
7.6
0.28
41
625
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
37
222
1.67
2.29
1.6
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
182
2253
0.80
2.28
1.5
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
262
2182
1.21
2.27
2.5
2.9
u/ml
0.4
0.4
0.22
150
1257
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
27
148
1.83
2.27
1.1
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
27
148
1.83
2.27
1.1
1.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
6
171
0.35
2.26
2.0
2.9
mg/l
6.2
7.4
—
6
135
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
102
761
1.34
2.20
1.1
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
47
304
1.55
2.17
1.3
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
399
4575
0.86
2.15
1.3
1.3
u/ml
132.2
180.4
1.66
360
4187
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1075
9898
1.10
2.14
4.6
4.8
%
34.3
33.6
1.07
644
6385
(3008898) HLA-B27 [Presence]
179
2200
0.81
2.12
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
38
595
0.64
2.09
1.2
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
46
691
0.66
2.09
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
109
830
1.32
2.07
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
316
3676
0.85
2.07
1.8
1.7
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
24
131
1.83
2.06
1.3
1.4
g/l
38.0
28.2
2.86
19
106
(3027923) C peptide [Moles/volume] in Serum or Plasma
20
367
0.54
2.04
1.3
1.5
nmol/l
0.9
1.2
0.81
15
285
(3004809) Band form neutrophils/100 leukocytes in Blood
144
1140
1.27
2.04
3.1
3.4
%
1.6
1.3
0.56
115
893
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
51
342
1.49
2.02
2.2
2.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
74
1013
0.73
2.02
1.1
1.1
u/ml
0.8
0.9
0.17
24
353
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
34
540
0.63
2.01
1.2
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
202
2436
0.82
2.00
3.0
3.3
ratio
2.1
4.5
0.40
14
193
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
34
537
0.63
1.97
1.2
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
11
242
0.45
1.93
6.3
10.1
nmol/l
780.5
883.4
0.23
11
234
(40761539) Cells [Type] in Urine sediment by Light microscopy
28
164
1.71
1.93
1.1
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
37
570
0.65
1.92
1.1
1.2
—
130.5
—
0
22
(21494814) CD8 cells/100 lymphocytes in Specimen
41
266
1.54
1.90
1.8
2.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
261
3059
0.85
1.90
1.9
2.3
g/l
7.6
7.6
0.04
193
2222
(40760888) Immunoglobulin light chains.free panel - Serum
153
1885
0.81
1.89
3.2
3.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
261
3053
0.85
1.86
1.9
2.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
305
2627
1.17
1.86
1.9
1.9
ug/l
1.2
2.3
2.88
280
2275
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
261
3051
0.85
1.85
1.9
2.3
g/l
3.7
3.7
0.10
185
2118
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
13
261
0.50
1.79
1.1
1.1
miu/ml
1694.2
1643.2
0.05
13
261
(3034860) Kappa light chains.free [Mass/volume] in Serum
212
2513
0.84
1.78
3.0
3.4
mg/l
41.1
70.1
0.66
162
2038
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
774
7086
1.10
1.77
2.1
2.4
u/l
37.2
39.6
0.21
654
5985
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
322
2798
1.16
1.76
2.8
3.2
u/ml
2869.5
1054.5
0.44
279
2340
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
27
436
0.62
1.75
1.2
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
686
7505
0.91
1.74
1.6
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
2732
26229
1.06
1.74
3.5
3.7
e6/l
119.0
121.0
0.04
1839
17832
(44806420)
10
218
0.46
1.74
2.4
2.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
109
853
1.28
1.74
1.3
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
85
643
1.32
1.74
2.4
3.0
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
212
2506
0.84
1.73
3.0
3.4
mg/l
42.3
42.8
0.02
165
2026
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
16
296
0.54
1.72
1.3
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
56
397
1.41
1.71
1.0
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
89
1153
0.77
1.71
1.3
1.5
g/l
0.5
0.7
0.99
70
858
(3019198) Lymphocytes [#/volume] in Blood
3870
37544
1.05
1.68
5.1
6.0
e9/l
1.7
1.9
13.18
3317
32756
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
579
6375
0.90
1.68
2.2
2.4
ug/l
5.3
5.9
0.44
466
5334
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
56
399
1.40
1.67
1.2
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
621
5643
1.11
1.67
7.2
6.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
3916
38010
1.05
1.66
5.2
6.1
e9/l
0.2
0.2
20.14
3327
33064
(3049242) von Willebrand panel - Platelet poor plasma
6
19
3.16
1.66
3.5
1.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
7
163
0.43
1.65
1.4
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
488
5418
0.89
1.65
2.2
2.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
153
1853
0.82
1.64
1.2
1.3
u/ml
32.8
50.7
0.73
16
223
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
266
3071
0.86
1.64
1.7
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
246
2856
0.86
1.63
1.9
2.4
g/l
3.1
3.1
0.04
189
2161
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
56
401
1.40
1.63
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
25
403
0.62
1.63
1.5
1.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
102
801
1.28
1.61
1.2
1.2
u/l
21.0
20.7
0.06
91
647
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
53
377
1.41
1.61
1.4
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
53
377
1.41
1.61
1.4
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
411
3662
1.13
1.58
1.2
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
12
235
0.51
1.57
1.3
1.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
33
495
0.66
1.56
2.0
2.3
ml
623.7
626.2
0.01
19
355
(3002621) Streptococcal DNAse B [Units/volume] in Serum
11
50
2.20
1.56
1.1
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1361
14390
0.93
1.53
1.5
1.5
g/l
2.3
2.4
0.90
706
8102
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
12
233
0.51
1.53
1.9
1.7
ug/l
10.3
8.7
0.74
12
233
(3026389) Candida sp identified in Specimen by Organism specific culture
114
1411
0.80
1.53
1.4
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
57
771
0.74
1.52
1.1
1.1
u/ml
0.5
1.4
1.21
12
166
(3006922) Hepatitis E virus Ab [Presence] in Serum
60
443
1.36
1.48
1.1
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1347
12715
1.07
1.48
2.5
2.7
e6/l
1.2
1.4
1.30
722
7110
(3001019) Free T4 and TSH panel - Serum or Plasma
293
3328
0.88
1.47
1.8
1.8
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
91
1149
0.79
1.47
1.3
1.3
u/ml
89.2
59.9
—
7
100
(3014007) Fractional oxyhemoglobin in Arterial blood
479
4327
1.11
1.47
7.7
7.5
%
94.5
93.9
1.89
479
4311
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
50
359
1.39
1.46
1.3
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
17
94
1.81
1.46
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1076
11447
0.93
1.45
1.2
1.2
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
7
28
2.50
1.45
1.0
2.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
492
5414
0.90
1.45
3.7
3.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
250
2867
0.87
1.45
1.9
2.3
g/l
9.9
10.1
0.26
203
2344
(3016018) Differential panel - Cerebral spinal fluid
91
716
1.27
1.44
1.6
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
284
3228
0.87
1.44
1.7
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
354
3966
0.89
1.44
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
48
659
0.73
1.42
1.3
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
51
693
0.73
1.42
1.0
1.0
u/ml
5.9
3.1
0.50
17
243
(3018572) Chloride [Moles/volume] in Blood
131
1582
0.82
1.41
4.7
6.0
mmol/l
105.3
104.9
0.54
121
1420
(3039000) Anion gap in Blood
131
1581
0.83
1.40
4.6
6.0
mmol/l
10.4
11.0
1.58
121
1419
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
49
354
1.38
1.40
1.3
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
199
0.50
1.39
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
70
906
0.77
1.39
1.1
1.1
u/ml
6.9
2.6
0.64
25
411
(3035320) C reactive protein [Mass/volume] in Body fluid
72
553
1.30
1.38
1.9
2.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
735
7915
0.92
1.37
1.5
1.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
67
869
0.77
1.36
1.1
1.1
u/ml
1.4
0.8
0.31
22
328
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
477
4329
1.11
1.36
7.7
7.4
%
1.3
1.4
1.84
477
4299
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
55
733
0.75
1.36
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
139
1156
1.20
1.35
1.3
1.4
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
37
0.00
1.34
0.0
1.2
—
83.9
—
0
32
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
28
418
0.67
1.34
1.4
1.7
—
—
—
0
0
(4281824)
151
1268
1.19
1.33
1.2
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
299
2648
1.13
1.32
1.6
1.4
pmol/l
193.9
177.2
0.20
290
2588
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
474
4310
1.10
1.31
7.7
7.4
%
0.8
0.7
2.43
474
4284
(3003396) Base excess in Arterial blood by calculation
857
7998
1.08
1.31
5.9
6.1
mmol/l
1.1
1.3
0.96
714
6383
(3001604) Monocytes [#/volume] in Blood
3762
36631
1.05
1.31
5.0
5.9
e9/l
0.6
0.6
1.63
3154
31358
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
112
915
1.23
1.31
1.2
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
42
579
0.72
1.30
1.2
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
55
726
0.76
1.29
2.1
1.5
%
37.5
34.6
0.21
36
415
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
23
354
0.65
1.28
1.0
1.1
u/l
1.3
1.1
0.42
15
166
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
733
6807
1.08
1.28
3.0
3.2
ng/l
82.9
83.9
0.12
616
5695
(3004616) Nuclear Ab [Presence] in Serum
86
1071
0.80
1.27
1.4
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
3778
36811
1.05
1.27
5.0
5.9
e9/l
0.0
0.0
6.97
3160
31483
(3011544) Albumin [Mass/volume] in Pleural fluid
9
44
2.04
1.26
1.4
1.1
g/l
16.9
17.8
—
9
35
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
505
4617
1.10
1.26
1.3
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
82
651
1.26
1.25
1.3
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1838
19134
0.95
1.24
2.2
2.3
mg/l
3.1
3.1
0.04
1496
16281
(3007916) DNA double strand Ab [Titer] in Serum
5
117
0.43
1.24
1.2
1.2
—
256.5
—
0
8
(3008295) Osmolality of Serum or Plasma
100
813
1.23
1.24
1.4
1.4
mosm/kgh2o
276.4
274.3
0.41
77
601
(40763480) Human metapneumovirus Ag [Presence] in Specimen
8
36
2.22
1.24
1.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
19
115
1.65
1.24
1.1
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
193
2224
0.86
1.23
4.1
5.3
mmol/l
1.2
1.3
0.50
174
1971
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
171
1463
1.17
1.23
2.9
3.6
%
59.0
57.6
0.59
171
1463
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
545
5911
0.92
1.22
1.6
1.5
%
1.4
1.4
0.15
453
5095
(3028192) IgG subclass 2 [Mass/volume] in Serum
58
753
0.77
1.22
1.2
1.4
g/l
2.7
2.8
0.23
41
535
(3022217) INR in Platelet poor plasma by Coagulation assay
1039
9794
1.07
1.21
24.4
24.6
inr
1.3
1.3
0.25
130
1319
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
10
49
2.04
1.21
1.7
1.8
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
54
707
0.76
1.21
1.3
1.2
u/ml
7.7
43.9
—
7
61
(3027135) IgG subclass 1 [Mass/volume] in Serum
58
752
0.77
1.21
1.2
1.4
g/l
6.6
6.7
0.10
40
534
(3024139) IgG subclass 3 [Mass/volume] in Serum
58
752
0.77
1.21
1.2
1.4
g/l
0.4
0.4
0.09
42
534
(3008152) Bicarbonate [Moles/volume] in Arterial blood
409
4490
0.91
1.19
5.9
6.4
mmol/l
25.2
24.8
1.09
385
4173
(3038026) Centromere Ab [Units/volume] in Serum
56
728
0.77
1.19
1.3
1.2
—
56.8
—
0
35
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
7
145
0.48
1.19
1.1
1.7
—
27.3
—
0
15
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
41
557
0.73
1.18
1.0
1.1
u/ml
1.0
0.4
—
8
116
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
19
298
0.64
1.17
3.1
2.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
49
646
0.76
1.16
1.0
1.1
u/ml
4.4
2.8
0.27
19
233
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
427
4668
0.91
1.15
2.5
2.5
—
—
—
0
0
(1002224) Polysomnography panel
204
2327
0.87
1.15
1.1
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
8
39
2.05
1.15
1.5
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
328
3633
0.90
1.15
1.2
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1745
16733
1.05
1.14
1.6
1.7
mg/l
1.2
1.2
0.26
1346
12829
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
15
87
1.72
1.14
1.4
1.2
%
21.9
13.1
—
8
45
(3009466) Valproate [Moles/volume] in Serum or Plasma
70
878
0.79
1.13
3.8
4.9
umol/l
368.0
368.0
0.00
62
755
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
145
1235
1.18
1.13
3.8
4.6
iu/ml
748.3
929.0
0.14
13
188
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
118
987
1.20
1.13
1.3
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
176
2025
0.87
1.13
1.7
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
110
914
1.20
1.13
3.0
2.7
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
851
7994
1.07
1.12
6.0
6.1
kpa
13.6
12.5
5.25
816
7614
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
8
40
2.00
1.12
1.1
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
175
2012
0.87
1.11
2.0
2.0
mg/l
10.9
11.5
0.53
161
1842
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
152
1766
0.86
1.11
1.4
1.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
851
7997
1.07
1.11
6.0
6.1
kpa
5.1
5.1
0.24
816
7622
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
282
3142
0.89
1.11
2.0
2.0
u/l
41.1
39.6
0.65
240
2738
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
38
514
0.74
1.09
1.2
1.3
mmol/l
12.1
11.8
0.05
12
128
(3012501) Base excess in Blood by calculation
177
1537
1.15
1.09
3.1
3.5
mmol/l
2.7
2.8
0.12
141
1108
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
14
81
1.73
1.08
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
14
81
1.73
1.08
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
14
81
1.73
1.08
1.0
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
7
32
2.19
1.08
1.0
1.4
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
7
32
2.19
1.08
1.0
2.0
—
—
—
0
0
(3016750) Collection duration of Urine
26
374
0.69
1.07
2.0
2.2
min
466.1
501.2
1.87
17
288
(3008757) Leukocyte morphology finding [Identifier] in Blood
94
774
1.22
1.07
3.2
3.7
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
15
89
1.68
1.07
1.1
1.1
—
—
—
0
0
(4062490)
59
746
0.79
1.04
1.2
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
5642
57139
0.96
1.04
4.2
4.5
mm/h
14.3
13.7
2.55
5095
52629
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
123
1043
1.18
1.03
1.6
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
28
195
1.44
1.03
1.4
1.3
%
56.6
61.2
0.30
23
160
(3009871) Measles virus Ab [Titer] in Serum
13
215
0.60
1.02
1.4
1.7
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
13
215
0.60
1.02
1.7
2.1
ug/l
1.5
2.5
—
7
124
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
229
2568
0.89
1.02
2.2
2.5
g/l
0.7
0.8
0.39
186
2151
(3025468) Yersinia sp identified in Specimen by Organism specific culture
122
1035
1.18
1.02
1.6
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
5232
51470
1.04
1.02
5.0
5.1
e6/l
5478.3
2539.1
1.06
59
652
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
45
587
0.76
1.02
1.0
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
84
688
1.22
1.02
1.8
2.3
u/field
2.6
2.4
0.07
37
253
(40765096) Chromosome analysis panel by Banding
26
179
1.45
1.02
1.2
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
41
541
0.76
1.01
1.2
1.4
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
14
83
1.69
1.01
1.2
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
65
808
0.80
1.00
1.1
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
41
540
0.76
1.00
1.2
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
2229
22978
0.96
1.00
2.9
3.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
341
3736
0.91
1.00
2.0
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1869
19338
0.96
0.99
3.8
3.9
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
41
539
0.76
0.99
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
41
539
0.76
0.99
1.2
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
24
344
0.70
0.99
1.3
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
386
4202
0.91
0.99
3.3
3.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
230
2571
0.89
0.98
1.6
1.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
212
2381
0.89
0.98
2.0
2.3
g/l
37.5
37.5
0.02
175
1992
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
46
352
1.31
0.98
1.1
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
27
189
1.43
0.98
2.1
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
4591
45077
1.04
0.97
3.0
3.0
u/l
47.8
44.6
1.19
4143
41318
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
65
804
0.81
0.97
1.0
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
3265
33381
0.96
0.97
2.0
2.0
pmol/l
99.6
98.9
0.30
1411
15503
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
13
211
0.61
0.96
1.5
1.2
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
24
165
1.45
0.96
1.3
1.3
%
3.6
3.6
0.01
19
136
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
53
670
0.79
0.96
1.0
1.1
—
104.6
—
0
9
(44813793)
43
558
0.77
0.95
1.2
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
633
6743
0.93
0.95
2.6
2.9
ng/l
202.9
190.4
0.29
577
6150
(3006270) Folate [Moles/volume] in Blood
83
686
1.21
0.94
1.2
1.2
nmol/l
336.2
352.7
0.30
74
567
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
121
1035
1.17
0.94
1.6
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
38
500
0.76
0.94
1.1
1.4
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
6
116
0.52
0.94
1.2
1.3
nmol/l
20.1
24.8
—
6
92
(3000285) Sodium [Moles/volume] in Blood
6
118
0.51
0.93
1.5
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
197
0.61
0.93
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
197
0.61
0.93
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
197
0.61
0.93
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
197
0.61
0.93
1.1
1.1
—
—
—
0
0
(4027681)
25
351
0.71
0.93
1.4
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
13
209
0.62
0.93
1.7
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
45
347
1.30
0.92
8.3
11.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
121
1039
1.17
0.90
1.6
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
837
8817
0.94
0.90
1.3
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
144
1644
0.87
0.88
1.5
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
122
1051
1.16
0.88
1.6
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
110
940
1.17
0.88
2.2
2.2
u/ml
488.3
752.3
—
6
49
(43055514) Macroprolactin [Presence] in Serum or Plasma
13
79
1.64
0.87
1.5
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
137
1192
1.15
0.87
1.7
1.7
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
318
3466
0.91
0.87
3.0
3.0
mmol/l
25.6
25.5
0.22
310
3372
(3029634) Reagin Ab [Titer] in Serum by VDRL
51
637
0.80
0.86
1.6
1.5
—
2.0
—
0
5
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
54
670
0.80
0.85
1.3
1.2
u/ml
2.2
5.1
—
5
48
(3036071) Salmonella sp Ab [Titer] in Serum
25
178
1.40
0.85
1.0
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
278
2531
1.10
0.84
3.9
3.8
mmol/l
25.3
25.2
0.21
255
2284
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
38
291
1.31
0.83
1.9
1.6
ug/l
0.4
0.4
0.11
25
187
(3023487) Leukocytes [#/volume] in Peritoneal fluid
32
239
1.34
0.83
1.9
1.9
e6/l
1195.5
3193.0
0.43
16
151
(3021387) Prolactin [Units/volume] in Serum or Plasma
119
1369
0.87
0.83
1.7
1.7
mu/l
324.6
324.8
0.00
111
1224
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
137
0.58
0.83
1.3
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
311
2850
1.09
0.82
3.6
3.5
—
—
—
0
0
(3001729) Color of Synovial fluid
11
65
1.69
0.82
2.7
1.7
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
6
32
1.87
0.81
1.0
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
57
698
0.81
0.81
1.1
1.1
—
41.8
—
0
8
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
13
81
1.60
0.80
1.3
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
46
364
1.26
0.80
1.9
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
89
755
1.18
0.80
1.0
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
268
2929
0.91
0.79
3.8
4.6
%
0.9
0.9
0.28
257
2746
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
184
2050
0.89
0.79
2.1
2.4
g/l
0.0
0.0
0.00
164
1872
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
2.5
—
0
18
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
123
1072
1.15
0.79
1.6
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
511
5438
0.93
0.78
2.9
2.9
g/l
9.9
10.3
1.13
459
4976
(3021879) Hepatitis B virus core Ab [Presence] in Serum
435
4053
1.08
0.78
1.2
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
31
233
1.33
0.78
1.0
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
10
163
0.61
0.78
1.0
1.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
200
2216
0.90
0.78
2.0
2.4
g/l
0.0
0.0
0.73
177
2004
(3034891) Synovial lining cells/100 cells in Synovial fluid
29
384
0.75
0.78
1.7
1.4
%
3.4
3.8
0.08
11
68
(3025549) Creatine [Moles/time] in 24 hour Urine
12
74
1.62
0.77
1.8
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
187
2077
0.90
0.77
2.0
2.4
g/l
0.0
0.0
0.29
165
1877
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
28
0.00
0.76
0.0
2.0
—
3.4
—
0
28
(3015183) Erythrocyte sedimentation rate
34
261
1.30
0.75
1.2
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
440
4698
0.93
0.75
3.7
4.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
272
2960
0.92
0.75
3.8
4.5
%
1.6
1.6
0.26
261
2775
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
24
2.08
0.74
3.4
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
35
447
0.78
0.73
1.1
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
17
116
1.46
0.73
3.3
1.6
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
11
172
0.64
0.73
1.4
1.9
e6/l
382.0
259.6
—
5
97
(3002523) Influenza virus A Ag [Presence] in Specimen
88
753
1.17
0.73
1.0
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
590
5573
1.06
0.72
2.9
3.2
pmol/l
4.4
4.4
0.15
522
4875
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
442
4136
1.07
0.72
1.4
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
984
10248
0.95
0.72
7.1
7.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
64
533
1.20
0.72
1.3
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
31
401
0.77
0.72
2.6
2.4
u/ml
2678.1
1133.4
0.38
31
396
(3020961) Endomysium IgA Ab [Titer] in Serum
329
3544
0.92
0.72
1.1
1.1
titre
508.4
196.9
—
9
71
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
28
367
0.76
0.72
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
63
752
0.84
0.72
1.6
2.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
194
0.67
0.71
1.0
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
295
3187
0.92
0.70
1.7
1.6
g/l
1.6
1.6
0.20
245
2712
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1158
11146
1.04
0.69
1.4
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
25
186
1.34
0.69
1.0
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
102
889
1.15
0.68
1.1
1.1
%
126.4
123.0
0.38
91
787
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
10
61
1.64
0.68
1.0
1.1
—
—
—
0
0
(4146454)
95
824
1.15
0.68
2.4
2.7
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
399
4254
0.93
0.67
2.6
3.0
g/l
123.3
126.0
1.90
392
4155
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
12
180
0.67
0.67
1.3
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
42
518
0.81
0.67
1.0
1.0
ng/l
48.2
45.4
0.17
31
349
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
7
43
1.63
0.66
1.0
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
412
3862
1.07
0.66
3.4
3.4
mmol/l
2.2
2.1
0.12
327
2992
(3000492) Spirometry study
670
6375
1.05
0.66
1.4
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
100
1138
0.88
0.64
1.2
1.3
nmol/l
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
37
459
0.80
0.63
1.2
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
129
0.62
0.63
1.4
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
335
3124
1.07
0.63
3.8
3.7
mmol/l
24.6
24.5
0.31
295
2802
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
135
1505
0.89
0.63
1.3
1.3
mmol/l
3.6
3.7
1.14
127
1415
(3011288) Drugs identified in Urine by Screen method
57
676
0.84
0.63
2.0
1.8
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
41
502
0.82
0.63
1.0
1.1
iu/ml
5.6
11.1
—
10
97
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
97
1103
0.88
0.62
1.1
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
83
954
0.87
0.62
1.2
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
50
414
1.21
0.62
1.5
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
40
490
0.81
0.62
1.7
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
37
457
0.81
0.62
1.2
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
157
1418
1.11
0.61
1.4
1.6
—
—
—
0
0
(3020891) Body temperature
275
2958
0.93
0.61
4.0
4.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
28
357
0.78
0.61
1.1
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
10
152
0.66
0.61
1.0
1.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
28
217
1.29
0.61
4.2
3.0
ng/l
65.0
150.4
—
9
60
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
59
498
1.18
0.61
1.6
1.9
%
14.4
14.4
0.00
14
216
(4024509)
109
965
1.13
0.60
1.8
1.7
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
42
510
0.82
0.60
1.0
1.0
ng/l
1192.5
359.2
0.47
30
347
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
13
88
1.48
0.60
1.0
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
747
7149
1.05
0.60
2.1
2.1
nmol/l
390.1
377.1
0.96
685
6462
(1175426) CD3 cells/100 lymphocytes in Blood
60
508
1.18
0.60
1.6
1.9
%
70.7
72.7
0.42
55
480
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
64
545
1.17
0.60
1.3
1.3
—
—
—
0
0
(3010421) pH of Blood
197
1803
1.09
0.60
3.0
3.4
ph
7.4
7.4
0.04
174
1500
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
136
1509
0.90
0.59
1.5
1.4
e6/l
794.6
1315.3
0.54
100
1244
(3038177) Helicobacter pylori Ab [Presence] in Serum
108
1214
0.89
0.59
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
146
1613
0.90
0.59
1.3
1.3
miu/ml
217.7
214.2
0.04
66
736
(3043238) Trisomy 21 risk [Likelihood] in Fetus
39
476
0.82
0.59
1.2
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
136
1507
0.90
0.58
1.5
1.4
e6/l
26.4
31.5
0.11
90
1182
(40767503) Oxygen content in Capillary blood by calculation
161
1461
1.10
0.58
2.4
2.5
%
16.4
15.9
0.68
73
738
(3020874) Milk IgE Ab [Units/volume] in Serum
26
332
0.78
0.58
1.0
1.0
u/ml
0.4
1.3
—
10
105
(3003181) Sodium [Moles/volume] in Urine
179
1636
1.09
0.57
1.3
1.4
mmol/l
67.3
61.6
0.85
137
1293
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
6
36
1.67
0.56
3.7
3.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
89
1008
0.88
0.56
1.8
1.5
%
58.3
55.3
0.32
59
606
(21494815) CD4 cells/100 lymphocytes in Specimen
60
512
1.17
0.56
2.1
2.0
%
35.4
44.8
—
9
61
(4306422)
104
924
1.13
0.56
1.1
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
901
8677
1.04
0.56
1.4
1.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
97
1092
0.89
0.56
1.3
1.4
mu/l
70.7
52.1
0.44
84
970
(3017354) Segmented neutrophils/100 leukocytes in Blood
83
727
1.14
0.55
3.3
3.3
%
59.9
58.1
0.24
49
480
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
56
476
1.18
0.55
1.5
2.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
206
2227
0.92
0.54
3.9
4.0
mmol/l
3.8
3.8
0.50
194
2104
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
43
514
0.83
0.54
1.0
1.0
ng/l
756.3
703.4
0.28
31
332
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
15
205
0.73
0.54
2.0
1.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
906
8735
1.04
0.54
6.2
6.1
mmol/l
104.0
104.0
0.02
886
8556
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2340
22918
1.03
0.53
2.8
2.9
ng/l
1346.0
1289.6
0.28
1971
19576
(3038071) Oxygen [Partial pressure] in Mixed venous blood
14
99
1.41
0.53
9.1
7.4
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
10
147
0.68
0.53
1.1
1.1
%
111.7
115.1
—
10
138
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
15
108
1.39
0.52
1.0
1.0
ug/l
93.7
76.3
—
10
80
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
76
665
1.14
0.52
1.1
1.1
%
93.4
93.7
0.03
71
623
(3016879) Cocaine [Presence] in Urine
81
916
0.88
0.51
2.6
1.4
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
50
424
1.18
0.51
1.6
2.0
u/field
1.0
2.3
2.18
37
283
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
12
83
1.44
0.51
1.2
1.7
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
9
136
0.66
0.51
1.0
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
26
325
0.80
0.51
1.4
1.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
72
630
1.14
0.50
2.4
2.2
e9/l
0.9
1.2
2.15
48
389
(3025315) Body weight
6
41
1.46
0.50
5.5
5.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
6
41
1.46
0.50
1.2
1.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
575
5994
0.96
0.49
2.3
2.5
e9/l
68.0
71.0
1.20
430
4470
(3019309) Folate [Moles/volume] in Red Blood Cells
1531
15669
0.97
0.49
1.8
1.8
nmol/l
1146.5
1195.4
1.15
1081
11625
(3052592) Norovirus Ag [Presence] in Stool
12
167
0.72
0.49
1.3
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
15
110
1.36
0.48
8.8
7.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
239
2553
0.93
0.48
3.0
2.9
g/l
0.2
0.3
4.93
80
833
(1001926) Buprenorphine [Presence] in Urine by Screen method
69
784
0.88
0.48
2.9
1.4
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
14
189
0.74
0.48
1.4
1.5
mmol/l
7.9
8.5
—
6
107
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
35
420
0.83
0.48
3.1
2.3
e9/l
0.2
0.2
0.17
29
359
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
26
208
1.25
0.47
2.1
1.7
e6/l
5291.8
23682.2
—
10
99
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
115
1042
1.10
0.46
1.1
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
190
2043
0.93
0.46
1.2
1.2
titre
221.7
930.1
—
6
85
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
37
440
0.84
0.46
3.0
2.2
e6/l
523.5
489.7
0.19
30
361
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
81
0.62
0.45
1.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
254
2383
1.07
0.45
1.2
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
86
769
1.12
0.45
1.3
1.3
—
—
—
0
0
(3036603) Volume of Urine
45
523
0.86
0.44
1.5
1.5
ml
1568.8
1932.4
—
9
124
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
12
163
0.74
0.43
1.3
1.2
nmol/l
91.5
116.4
—
6
109
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
17
219
0.78
0.43
1.1
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
421
4016
1.05
0.43
3.4
3.5
ph
7.4
7.4
1.44
59
552
(3012494) Peanut IgE Ab [Units/volume] in Serum
13
174
0.75
0.43
1.0
1.0
u/ml
0.1
1.2
—
6
87
(3014051) Protein [Presence] in Urine by Test strip
184
1973
0.93
0.43
2.3
2.3
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
27
220
1.23
0.43
2.6
1.9
%
162.2
176.0
0.36
27
205
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1566
15312
1.03
0.42
2.5
2.6
e6/l
8.5
7.5
0.97
1349
13261
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2398
24344
0.98
0.42
2.5
2.5
u/l
60.6
58.4
0.68
2154
22163
(3021901) Oxygen saturation in Capillary blood
126
1155
1.09
0.42
2.5
2.8
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
54
616
0.87
0.42
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
54
616
0.87
0.42
1.1
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
312
3284
0.95
0.42
1.1
1.1
u/ml
1.0
1.9
—
9
52
(3025159) Blasts/100 leukocytes in Blood
545
5659
0.96
0.41
3.7
4.1
%
0.6
0.3
0.22
179
1259
(3033799) Differential panel - Peritoneal fluid
25
203
1.23
0.41
2.1
1.7
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
22
176
1.25
0.41
1.1
1.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
54
615
0.88
0.41
1.1
1.2
—
—
—
0
0
(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid
0
16
0.00
0.41
0.0
3.1
—
1.5
—
0
16
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
24
195
1.23
0.40
1.5
1.2
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
18
0.00
0.40
0.0
8.3
—
622.2
—
0
13
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.1
—
7.9
—
0
8
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
7
102
0.69
0.39
1.1
1.2
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
10
137
0.73
0.39
1.3
1.9
mmol/l
1.2
1.2
—
10
132
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
91
825
1.10
0.39
5.2
6.4
mg/l
11.7
12.5
1.18
82
742
(3006653) Thiamine [Moles/volume] in Blood
27
324
0.83
0.39
1.1
1.3
nmol/l
146.5
134.4
0.55
27
324
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
19
0.00
0.39
0.0
2.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
10
71
1.41
0.39
1.2
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
408
4254
0.96
0.39
1.8
1.9
g/l
1.3
1.4
0.61
364
3843
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
488
4689
1.04
0.38
1.8
1.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
44
381
1.15
0.38
1.3
1.3
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
11
80
1.37
0.38
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
19
236
0.80
0.38
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
109
999
1.09
0.38
1.1
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
125
1153
1.08
0.38
1.7
1.8
u/l
4554.3
3751.7
0.11
42
458
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
162
1733
0.93
0.37
1.5
1.7
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
55
619
0.89
0.36
1.1
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
22
267
0.82
0.36
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
525
5433
0.96
0.36
1.2
1.2
iu/ml
144.3
145.1
0.02
197
2096
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
9
71
1.27
0.36
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
55
618
0.89
0.36
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
55
618
0.89
0.36
1.1
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2863
28958
0.98
0.35
3.7
3.7
ng/l
34.4
69.9
1.15
1981
19765
(3039744) RNA polymerase III Ab [Units/volume] in Serum
5
76
0.66
0.35
1.0
1.0
—
6.6
—
0
11
(3034274) Bile acid [Moles/volume] in Serum --fasting
45
512
0.88
0.35
1.3
1.7
umol/l
6.2
8.6
0.86
27
370
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
195
2067
0.94
0.35
1.1
1.1
u/ml
7.0
9.4
0.36
25
210
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
106
1149
0.92
0.35
1.7
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
111
1023
1.09
0.35
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
101
1097
0.92
0.35
1.6
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
18
144
1.25
0.35
1.2
2.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
423
4065
1.04
0.34
3.5
3.5
kpa
5.3
5.2
0.43
395
3729
(3021960) Folate [Moles/volume] in Serum or Plasma
1853
18816
0.98
0.34
1.5
1.5
nmol/l
21.7
21.7
0.02
1507
15755
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
6
44
1.36
0.34
8.8
4.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
607
6255
0.97
0.34
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
227
2390
0.95
0.33
1.1
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
198
2092
0.94
0.33
3.8
4.8
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
15
118
1.27
0.33
1.4
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
105
969
1.08
0.33
1.2
1.2
u/ml
3.4
3.5
0.04
31
307
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
103
950
1.08
0.33
1.1
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
114
1056
1.08
0.33
1.1
1.1
au/ml
8.7
14.4
—
5
33
(3007566) Smooth muscle Ab [Titer] in Serum
191
2019
0.94
0.33
1.2
1.2
titre
203.3
174.6
0.12
15
163
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
161
1710
0.94
0.32
1.3
1.3
mg/l
567.2
518.8
0.41
154
1619
(3040151) Glucose [Moles/volume] in Capillary blood
83
759
1.09
0.32
6.6
5.8
mmol/l
7.1
7.5
0.46
72
621
(3045716) Anion gap in Serum or Plasma
34
294
1.16
0.32
3.3
2.3
mmol/l
8.9
9.0
0.08
26
222
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
24
284
0.84
0.32
1.0
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
94
1017
0.92
0.31
1.2
1.3
pmol/l
575.0
286.2
0.45
74
794
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
26
220
1.18
0.31
1.0
1.1
%
89.3
90.4
0.05
13
93
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
32
276
1.16
0.31
1.1
1.0
%
100.4
93.9
0.53
24
202
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
39
342
1.14
0.31
1.9
1.8
%
109.6
100.1
1.02
34
313
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
31
267
1.16
0.31
1.6
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
96
0.73
0.30
2.7
1.9
umol/l
14.0
19.0
—
7
96
(3016038) Potassium [Moles/volume] in Urine
53
589
0.90
0.30
1.1
1.2
mmol/l
39.7
33.3
1.25
47
476
(3028707) Methadone [Presence] in Urine by Screen method
43
484
0.89
0.30
3.8
1.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
15
120
1.25
0.30
1.0
1.0
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
23
271
0.85
0.29
1.9
3.1
umol/l
26.4
27.9
0.24
14
202
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
13
102
1.27
0.29
1.2
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
213
2235
0.95
0.29
1.9
1.8
iu/l
4.5
8.5
0.50
67
792
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
48
535
0.90
0.29
1.5
1.3
nmol/l
1.6
1.4
0.54
41
486
(3000034) Microalbumin [Mass/volume] in Urine
62
681
0.91
0.29
2.4
2.9
mg/l
25.0
25.6
0.02
41
458
(3004451) EKG impression Narrative
33
376
0.88
0.28
1.3
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
51
565
0.90
0.28
1.1
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
74
804
0.92
0.28
5.5
4.6
u/ml
77.3
147.4
0.50
17
226
(42529406) Shigella sp [Presence] in Stool by Culture
232
2424
0.95
0.28
1.1
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
721
7032
1.03
0.27
6.4
6.4
%
96.1
95.8
0.62
704
6758
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
9
117
0.77
0.27
3.1
2.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
9
117
0.77
0.27
1.1
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
137
1451
0.94
0.27
3.2
3.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
882
8626
1.02
0.27
2.2
2.4
umol/l
7.1
7.2
0.07
741
7339
(3017569) Oxygen content in Arterial blood
34
299
1.14
0.27
2.5
2.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
139
1470
0.94
0.26
1.6
1.5
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
25
215
1.16
0.26
1.0
1.1
%
97.8
95.0
0.11
13
94
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
67
1.19
0.26
1.0
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
73
0.68
0.26
1.0
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
240
2299
1.04
0.26
1.7
1.7
mg/l
2.6
3.3
1.02
169
1638
(3014765) Yersinia sp identified in Stool by Organism specific culture
232
2418
0.96
0.26
1.1
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1471
14916
0.98
0.25
3.3
3.8
ng/l
129.6
261.2
3.35
1156
11574
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
318
3291
0.96
0.25
2.2
2.6
%
0.7
0.7
0.84
302
3153
(37021550) Renin [Units/volume] in Plasma --upright
20
169
1.18
0.25
1.1
1.2
mu/l
194.2
82.2
0.50
12
121
(3018851) Theophylline [Moles/volume] in Serum or Plasma
9
74
1.22
0.25
1.3
1.7
umol/l
72.8
45.3
—
9
74
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
14
170
0.82
0.25
1.5
2.5
mmol/l
6.2
7.2
—
7
102
(3044242) Glucose [Moles/volume] in Arterial blood
36
320
1.12
0.25
2.2
2.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
9
75
1.20
0.25
1.0
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
43
476
0.90
0.25
1.3
1.6
u/l
4.5
5.7
1.98
30
405
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
150
1577
0.95
0.24
2.1
2.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
17
142
1.20
0.24
1.3
1.5
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
81
869
0.93
0.24
1.1
1.1
g/l
1.5
1.5
0.18
73
775
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
61
560
1.09
0.24
1.6
1.3
titre
41.3
62.3
—
8
39
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
77
1.17
0.24
1.0
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
62
672
0.92
0.24
1.6
1.6
u/ml
16.7
24.2
1.18
11
137
(3032057) Clostridioides difficile [Presence] in Stool
17
201
0.84
0.24
2.1
1.7
—
—
—
0
0
(3048879) Bone marrow aspiration report
19
222
0.85
0.23
2.5
1.7
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
12
147
0.82
0.23
5.1
6.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
114
1206
0.94
0.23
1.2
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
62
571
1.09
0.23
1.5
1.3
titre
152.0
501.8
—
5
45
(3026008) Bacteria identified in Urine by Culture
2838
28601
0.99
0.23
3.3
3.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
72
668
1.08
0.23
1.8
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
41
370
1.11
0.23
1.9
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
36
400
0.90
0.22
1.0
1.1
—
—
—
0
0
(44806071)
7
91
0.77
0.22
1.1
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
548
5605
0.98
0.22
6.1
6.2
mmol/l
9.3
9.6
0.60
523
5284
(3045424) Erythrocytes [Presence] in Urine
128
1347
0.95
0.22
1.5
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
35
389
0.90
0.22
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
18
210
0.86
0.22
1.1
1.2
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
5
41
1.22
0.22
1.0
1.1
s
34.0
36.6
—
5
36
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1143
11593
0.98
0.21
2.1
2.4
umol/l
12.1
12.3
0.71
1043
10561
(3014599) Egg white IgE Ab [Units/volume] in Serum
28
315
0.89
0.21
1.0
1.0
u/ml
0.6
0.5
0.20
11
80
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
45
492
0.91
0.21
1.1
1.2
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
80.0
—
0
5
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
10
0.00
0.21
0.0
7.8
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009883) Potato IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.0
—
0
6
(3021367) Citalopram [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
119.4
—
0
5
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
1.7
—
0
12
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
16
135
1.18
0.21
8.7
4.8
u/l
37.8
47.4
—
5
54
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
39
429
0.91
0.21
2.9
2.4
e6/l
695.7
731.0
0.08
18
178
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
83
883
0.94
0.21
1.1
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
810
7947
1.02
0.21
2.2
2.4
%
1.8
1.8
1.70
715
6926
(40768441) Liver Pathology biopsy report
58
536
1.08
0.21
1.2
1.3
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
13
0.00
0.21
0.0
5.1
—
344.2
—
0
13
(3034614) HLA Ag [Interpretation]
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
11
134
0.82
0.20
4.7
4.8
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
155
0.84
0.20
1.1
1.1
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
670
6564
1.02
0.20
6.8
6.7
g/l
117.7
117.9
0.07
654
6322
(3003458) Phosphate [Moles/volume] in Serum or Plasma
945
9294
1.02
0.19
4.5
4.6
mmol/l
1.0
1.0
0.17
860
8490
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
159
1656
0.96
0.19
3.0
3.2
u/ml
308.3
563.2
0.49
141
1490
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
165
0.85
0.19
1.0
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
12
99
1.21
0.19
1.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
20
228
0.88
0.19
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
39
356
1.09
0.18
1.6
1.8
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
61
569
1.07
0.18
6.0
6.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
91
861
1.06
0.18
1.9
2.0
pg
32.5
32.2
0.26
91
852
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
34
373
0.91
0.18
1.6
2.0
ug/l
71.5
53.6
0.80
34
361
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
56
522
1.07
0.17
1.2
1.4
mmol/l
2.4
2.1
0.56
50
485
(3047007) Chlamydophila sp Ab [Presence] in Serum
103
980
1.05
0.17
1.2
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
35
382
0.91
0.17
1.1
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
7
63
1.11
0.17
1.1
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
70
0.71
0.16
1.4
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
14
162
0.86
0.16
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
150
1555
0.96
0.16
1.2
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
8
72
1.11
0.16
11.8
11.9
mmol/l
4.0
4.6
—
8
72
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
13
151
0.86
0.16
1.5
1.6
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
30
273
1.10
0.16
1.1
1.1
ng/l
97.4
298.7
—
7
66
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
6
78
0.77
0.15
1.3
1.3
pmol/l
25.8
16.7
—
6
71
(3015235) Bicarbonate [Moles/volume] in Capillary blood
156
1614
0.96
0.15
2.6
2.9
mmol/l
25.8
25.4
0.48
131
1428
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
47
503
0.93
0.15
1.2
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
6
80
0.75
0.15
2.2
2.3
pmol/l
62.8
84.2
—
6
68
(3019977) pH of Arterial blood
40
370
1.08
0.15
2.7
2.9
ph
7.4
7.4
0.11
16
127
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2062
20761
0.99
0.15
1.6
1.6
mmol/l
1.3
1.3
3.17
1687
17270
(3036670) Protein [Mass/volume] in Synovial fluid
29
264
1.10
0.15
1.3
1.3
g/l
39.4
39.7
0.05
14
132
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
82
1.10
0.14
1.1
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
13
150
0.87
0.14
1.5
2.0
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
125
1297
0.96
0.14
1.2
1.3
nmol/l
0.1
0.3
1.70
11
87
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
36
388
0.93
0.14
1.1
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
36
388
0.93
0.14
1.1
1.1
ratio
1.0
1.1
1.03
15
135
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
721
7302
0.99
0.14
1.4
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
176
1812
0.97
0.14
1.5
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
17
191
0.89
0.14
1.0
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
521
5290
0.98
0.14
2.7
2.9
kpa
4.6
4.5
0.43
500
5137
(40758292) HTLV I+II Ab panel - Serum
10
84
1.19
0.13
1.3
1.4
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
23
208
1.10
0.13
1.2
1.3
%
26.0
20.4
—
7
35
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
27
294
0.92
0.13
1.9
1.9
umol/l
308.6
121.6
0.82
17
166
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
14
159
0.88
0.13
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
119
1232
0.96
0.13
1.7
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
9
106
0.85
0.13
1.9
1.8
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
11
94
1.17
0.13
1.1
1.1
ng/l
19.5
57.8
—
5
57
(3021447) Carbon dioxide [Partial pressure] in Venous blood
631
6390
0.99
0.12
3.3
3.4
kpa
5.8
5.8
0.11
608
6214
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
34
316
1.08
0.12
1.5
1.4
pmol/l
16.8
15.8
0.48
27
261
(3028626) Oxygen [Partial pressure] in Capillary blood
140
1356
1.03
0.12
2.5
2.8
kpa
8.1
8.1
0.20
130
1266
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
29
313
0.93
0.12
1.1
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
632
6232
1.01
0.12
3.7
4.0
%
1.4
0.8
3.75
232
1586
(3051387) C reactive protein [Mass/volume] in Capillary blood
157
1613
0.97
0.12
3.8
3.6
mg/l
26.8
25.7
0.12
90
1008
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
998
9874
1.01
0.11
2.1
2.5
%
20.8
21.0
0.21
861
8228
(3026250) Tacrolimus [Mass/volume] in Blood
19
209
0.91
0.11
30.0
32.2
ug/l
7.5
7.1
0.60
19
184
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
19
209
0.91
0.11
1.0
1.2
pmol/l
194.1
363.2
2.33
14
142
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1052
10606
0.99
0.11
2.1
2.4
g/l
2.3
2.4
0.79
954
9680
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
95
915
1.04
0.11
1.2
1.1
u/ml
5.6
3.5
0.40
34
357
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
96
994
0.96
0.11
1.1
1.2
u/ml
300.2
294.9
0.06
62
599
(3024928) Oxygen saturation in Venous blood
140
1360
1.03
0.10
2.2
3.0
—
—
—
0
0
(4268621)
63
657
0.96
0.10
2.3
2.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
125
0.88
0.10
1.0
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
189
1931
0.98
0.10
1.9
1.6
e6/l
13272.6
12520.1
0.08
142
1378
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
96
1.14
0.10
1.6
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
196
2001
0.98
0.10
2.3
2.4
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
32
300
1.07
0.09
1.3
1.2
—
—
—
0
0
(4015189)
19
207
0.92
0.09
2.0
2.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
108
1111
0.97
0.09
1.3
1.3
—
20.6
—
0
19
(3006184) Hemoglobin [Mass/volume] in Capillary blood
167
1631
1.02
0.09
2.1
2.2
g/l
129.4
126.2
0.80
107
1145
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
235
2391
0.98
0.09
1.9
2.2
ug/l
349.7
582.8
1.21
207
2216
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
18
196
0.92
0.09
1.3
1.3
%
31.5
36.7
—
10
129
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
103
1059
0.97
0.09
1.1
1.2
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
6
54
1.11
0.09
1.0
1.3
—
19.4
—
0
16
(3028300) Cannabinoids [Presence] in Urine
98
1008
0.97
0.09
2.4
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
39
370
1.05
0.08
1.2
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
63
0.79
0.08
1.0
1.0
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
32
338
0.95
0.08
1.8
2.8
%
45.0
41.7
—
9
119
(3007461) Platelets [#/volume] in Blood
7960
79461
1.01
0.08
25.2
21.4
e9/l
258.6
261.3
3.23
7749
77033
(3020191) Ethanol [Moles/volume] in Serum or Plasma
34
358
0.95
0.08
1.3
1.5
promille
0.9
1.1
0.28
26
260
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
4092
40982
1.00
0.08
2.6
2.7
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
6
71
0.84
0.07
2.0
1.9
mg/l
1.2
1.7
—
6
56
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
11
98
1.12
0.07
1.0
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
13
143
0.91
0.07
1.1
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
76
1.05
0.07
4.6
6.5
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
7
85
0.82
0.07
1.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
15
163
0.92
0.07
1.5
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
32
336
0.95
0.07
1.1
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
32
336
0.95
0.07
1.1
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
98
1003
0.98
0.07
2.4
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
161
1637
0.98
0.06
2.9
3.1
mmol/l
1.6
1.5
0.15
161
1603
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
8
92
0.87
0.06
1.0
1.1
u/ml
144.5
46.1
—
8
87
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
72
740
0.97
0.06
1.5
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
591
5951
0.99
0.06
3.8
4.1
%
0.2
0.1
1.65
214
1466
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
158
1606
0.98
0.06
2.2
2.8
mg/l
1.5
1.6
1.25
138
1458
(3000764) Benzodiazepines [Presence] in Urine
98
1002
0.98
0.06
2.4
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
523
5269
0.99
0.06
2.4
2.4
au/ml
28.2
30.6
0.16
37
248
(3023511) Choriogonadotropin [Units/volume] in Urine
62
638
0.97
0.06
1.7
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
7961
79486
1.01
0.05
25.1
21.3
pg
30.3
30.2
7.89
7830
78116
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
55
533
1.03
0.05
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
97
949
1.02
0.05
1.2
1.2
u/ml
3.8
4.0
0.11
42
394
(3033705) Calcium.ionized [Moles/volume] in Venous blood
94
959
0.98
0.05
2.2
2.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
484
4798
1.01
0.05
1.3
1.3
au/ml
73.6
49.2
1.09
24
201
(3020491) Glucose [Moles/volume] in Blood
49
474
1.03
0.05
1.3
2.0
mmol/l
6.1
6.9
3.22
27
322
(3024731) MCV [Entitic volume]
7961
79489
1.01
0.05
25.1
21.3
fl
91.7
91.2
18.15
7830
78121
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
29
303
0.96
0.05
6.2
3.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
16
171
0.93
0.05
1.1
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
189
1865
1.01
0.05
3.2
3.3
nmol/l
0.8
0.8
0.16
147
1471
(3011648) Oxygen content in Venous blood
52
505
1.03
0.04
1.6
2.0
%
10.1
10.5
0.34
52
505
(3017732) Neutrophils [#/volume] in Blood
521
5237
0.99
0.04
2.9
3.0
e9/l
3.8
4.0
1.23
383
3839
(3025941) Bacteria identified in Stool by Culture
438
4346
1.01
0.04
1.2
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
72
704
1.02
0.04
3.8
3.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
7961
79496
1.01
0.04
25.2
21.4
e12/l
4.3
4.4
25.38
7734
76786
(3029075) Extractable nuclear Ab panel - Serum
23
219
1.05
0.04
1.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
26
249
1.04
0.04
2.3
2.7
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
30
311
0.96
0.04
1.2
1.3
%
58.3
63.5
—
6
33
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
51
497
1.03
0.03
1.1
1.1
mg/l
313.0
299.9
0.70
43
436
(40760892) CBC W Ordered Manual Differential panel - Blood
1565
15593
1.00
0.03
4.0
4.6
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
23
240
0.96
0.03
1.1
4.4
mg/l
58.9
981.8
0.50
15
158
(3024471) HLA-A [Type]
14
149
0.94
0.03
1.0
1.0
—
—
—
0
0
(4094501)
192
1936
0.99
0.03
1.1
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
182
1835
0.99
0.03
1.1
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
55
561
0.98
0.03
1.3
1.2
u/ml
1.2
1.2
0.02
21
278
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
18
171
1.05
0.03
1.0
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
74
727
1.02
0.03
1.9
1.4
e6/l
80826.2
130109.2
0.29
50
488
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
10
92
1.09
0.03
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
40
410
0.97
0.03
4.0
3.8
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
11
118
0.93
0.03
1.2
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
7961
79505
1.00
0.03
25.2
21.4
e9/l
6.3
6.6
17.25
7736
76800
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
363
3607
1.01
0.03
8.0
8.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
639
6360
1.00
0.03
1.4
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
18
188
0.96
0.02
4.9
2.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
199
1974
1.01
0.02
1.3
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
7961
79509
1.00
0.02
25.3
21.5
g/l
129.9
131.4
22.94
7832
78168
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
19
182
1.04
0.02
1.0
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
5243
52403
1.00
0.02
4.6
4.9
—
—
—
0
0
(4211845)
45
441
1.02
0.02
4.2
3.7
—
—
—
0
0
(4133840)
12
127
0.94
0.02
1.2
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
637
6380
1.00
0.02
3.3
3.4
mmol/l
2.2
2.1
0.04
521
5295
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
43
438
0.98
0.02
1.1
1.1
nmol/l
3.9
6.7
—
5
94
(40762365) Oxygen content in Arterial blood by calculation
11
103
1.07
0.01
1.5
2.4
ml/dl
13.9
14.6
0.85
11
94
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
18
187
0.96
0.01
1.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
91
900
1.01
0.01
2.7
2.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
183
1.04
0.01
1.0
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
635
6331
1.00
0.01
2.6
2.6
g/l
65.4
66.3
2.21
567
5634
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
52
527
0.99
0.01
2.3
2.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
55
542
1.01
0.01
2.1
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
25
243
1.03
0.01
1.2
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
117
1177
0.99
0.01
1.8
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
148
1470
1.01
0.01
1.2
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
45
443
1.01
0.01
3.1
3.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
568
5683
1.00
0.00
3.6
3.9
%
0.9
0.6
1.94
162
1141
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
314
3129
1.00
0.00
1.5
1.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
11
104
1.06
0.00
1.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
65
643
1.01
0.00
1.1
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
17
164
1.04
0.00
1.2
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
111
1115
0.99
0.00
1.3
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
16
163
0.98
0.00
1.0
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
16
163
0.98
0.00
1.1
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
42
422
0.99
0.00
1.1
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
36
364
0.99
0.00
1.9
1.9
ml
1853.1
1849.3
0.01
30
324
(4198724)
12
123
0.97
0.00
1.0
1.3
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
17
165
1.03
0.00
1.2
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
99
988
1.00
0.00
1.3
1.3
u/ml
97.1
121.2
1.63
21
228
(3027944) Amphetamines [Presence] in Urine
98
984
0.99
0.00
2.4
1.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
11
110
1.00
0.00
1.0
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
137
1371
1.00
0.00
1.5
1.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
19
187
1.02
0.00
1.3
1.3
ng/l
73.0
93.7
0.77
19
187
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
26
259
1.00
0.00
2.6
2.2
umol/l
51.2
56.4
0.40
21
195
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
15
155
0.97
0.00
1.1
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
21
214
0.98
0.00
2.5
3.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
21
214
0.98
0.00
2.5
3.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
58
574
1.01
0.00
1.1
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
32
323
0.99
0.00
1.4
1.3
nmol/l
0.8
1.1
1.31
23
253
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
30
295
1.02
0.00
1.0
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
19
195
0.97
0.00
1.2
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
11
108
1.02
0.00
2.1
3.0
u/field
0.8
0.9
0.08
11
108
(3023183) Ammonium ion [Moles/volume] in Plasma
117
1169
1.00
0.00
2.6
2.5
umol/l
34.6
32.2
0.58
95
986
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
18
185
0.97
0.00
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
67
672
1.00
0.00
1.7
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
34
340
1.00
0.00
1.3
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
22
222
0.99
0.00
1.1
1.4
—
—
—
0
0
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
6
69
0.87
0.00
1.3
1.1
—
—
—
0
0
(4212803)
7
72
0.97
0.00
1.0
1.1
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
9
0.00
0.00
0.0
4.0
—
244.9
—
0
9
(3018291) Platelet Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
7
71
0.98
0.00
2.6
1.3
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
7
73
0.96
0.00
1.7
2.6
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
7
74
0.94
0.00
1.0
1.0
—
—
—
0
0
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
54
0.92
0.00
1.0
1.1
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.3
—
90.6
—
0
9
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
9
95
0.95
0.00
2.6
3.1
—
34.8
—
0
13
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
26.3
—
0
6
(3008717) Parietal cell Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
436.3
—
0
8
(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3000876) Codfish IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
51
0.98
0.00
1.0
1.2
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
9
97
0.93
0.00
1.4
2.1
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline
0
8
0.00
0.00
0.0
1.0
—
310.4
—
0
8
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
65
0.92
0.00
6.0
4.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
83
0.96
0.00
1.0
1.0
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
68
0.88
0.00
1.0
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
52
0.96
0.00
1.4
1.2
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BREAST_ERNEG – Malignant neoplasm of breast, HER-negative
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).